<SEC-DOCUMENT>0000950103-25-014861.txt : 20251117
<SEC-HEADER>0000950103-25-014861.hdr.sgml : 20251117
<ACCEPTANCE-DATETIME>20251117173017
ACCESSION NUMBER:		0000950103-25-014861
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20251117
DATE AS OF CHANGE:		20251117

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARCLAYS BANK PLC
		CENTRAL INDEX KEY:			0000312070
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287303
		FILM NUMBER:		251492197

	BUSINESS ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP
		BUSINESS PHONE:		0044-20-3555-4619

	MAIL ADDRESS:	
		STREET 1:		1 CHURCHILL PLACE
		STREET 2:		CANARY WHARF
		CITY:			LONDON
		STATE:			X0
		ZIP:			E14 5HP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK PLC /ENG/
		DATE OF NAME CHANGE:	19990402

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BARCLAYS BANK INTERNATIONAL LTD
		DATE OF NAME CHANGE:	19850313
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp237479_424b2-stockarn1.htm
<DESCRIPTION>FORM 424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Product Supplement STOCK ARN-1 </FONT></TD>
    <TD STYLE="text-align: right; width: 50%">Filed Pursuant to Rule 424(b)(2)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">(To Prospectus dated May 15, 2025&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: right">Registration Statement No. 333-287303</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">and Series A Prospectus Supplement dated May 15, 2025)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="text-align: right">November 17, 2025</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_005.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Accelerated Return Notes<SUP>&reg;</SUP> &ldquo;ARNs<SUP>&reg;</SUP>&rdquo;
Linked to One or More Equity Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The ARNs are unsecured and unsubordinated obligations issued by Barclays Bank PLC.&nbsp;&nbsp;Any payments due on the ARNs, including
any repayment of principal, will be subject to the credit risk of Barclays Bank PLC and to the exercise of any U.K. Bail-in Power (as
defined below) by any relevant U.K. resolution authority (as described in the accompanying prospectus supplement).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The ARNs do not guarantee the return of principal at maturity, and we will not pay interest on the ARNs.&nbsp;&nbsp;Instead, the return
on the ARNs will be based on the performance of an underlying &ldquo;<B>Market Measure</B>,&rdquo; which will be either the common equity
securities or American Depositary Receipts (&ldquo;<B>ADRs</B>&rdquo;) of a company other than us, the agents and our respective affiliates
(the &ldquo;<B>Underlying Stock&rdquo;</B>). The Market Measure may also consist of a <B>&ldquo;Basket&rdquo;</B> of two or more Underlying
Stocks.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The ARNs provide an opportunity to earn a multiple (which will be 3 times, unless otherwise set forth in the applicable term sheet
(as defined below)) of the positive performance of the Market Measure, up to a specified cap (the &ldquo;<B>Capped Value</B>&rdquo;),
while exposing you to any negative performance of the Market Measure on a 1-to-1 basis.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the value of the Market Measure increases from its Starting Value to its Ending Value (each as defined below),&nbsp;&nbsp;you will
receive at maturity a cash payment per unit (the &ldquo;<B>Redemption Amount</B>&rdquo;) that equals the principal amount plus a multiple
of that increase, up to the Capped Value.&nbsp;&nbsp;If the value of the Market Measure does not change from its Starting Value to its
Ending Value, you will receive a Redemption Amount that equals the principal amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the value of the Market Measure decreases from its Starting Value to its Ending Value, you will be subject to 1-to-1 downside exposure
to that decrease.&nbsp;&nbsp;In such case, you may lose all or a significant portion of the principal amount of your ARNs.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>This product supplement describes the general terms of the ARNs, the risk factors to consider before investing, the general manner
in which they may be offered and sold, and other relevant information.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>For each offering of the ARNs, we will provide you with a pricing supplement (which we refer to as a &ldquo;<B>term sheet</B>&rdquo;)
that will describe the specific terms of that offering, including the specific Market Measure, the Capped Value, the Participation Rate
(as defined below), and certain related risk factors.&nbsp;&nbsp;The applicable term sheet will identify, if applicable, any additions
or changes to the terms specified in this product supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The ARNs will be issued in denominations of whole units.&nbsp;&nbsp;Unless otherwise set forth in the applicable term sheet, each
unit will have a principal amount of $10. The applicable term sheet may also set forth a minimum number of units that you must purchase.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Unless otherwise specified in the applicable term sheet, the ARNs will not be listed on a securities exchange or quotation system.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-size: 10pt">BofA Securities, Inc. (&ldquo;<B>BofAS</B>&rdquo;) and one or more of its affiliates may act as our
agents to offer the ARNs, and will act in a principal capacity in such role.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-top: Black 1pt solid; border-bottom: Black 1pt solid">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><I>The ARNs are our unsecured and unsubordinated
    obligations and are not deposit liabilities of Barclays Bank PLC.&nbsp;&nbsp;The ARNs are not covered by the U.K. Financial Services
    Compensation Scheme or insured by the U.S. Federal Deposit Insurance Corporation (the &ldquo;<B>FDIC</B>&rdquo;) or any other governmental
    agency or deposit insurance agency of the United States, the United Kingdom or any other jurisdiction.&nbsp;&nbsp;<B></B></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><I><B>&nbsp;</B></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><I><B>Potential purchasers
    of the ARNs should consider the information in &ldquo;Risk Factors&rdquo; beginning on page PS-6 of this product supplement and page
    S-9 of the accompanying prospectus supplement.</B> <B>You may lose all or a significant portion of your investment in the ARNs.</B></I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><I>None of the Securities and Exchange Commission
    (the &ldquo;<B>SEC</B>&rdquo;), any state securities commission, or any other regulatory body has approved or disapproved of these securities
    or passed upon the adequacy or accuracy of this product supplement or the accompanying prospectus supplement or prospectus.&nbsp;&nbsp;Any
    representation to the contrary is a criminal offense.</I></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt; text-indent: 0in"><B>BofA Securities</B></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="toc"></A>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Page</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="font-size: 10pt; text-align: left; vertical-align: bottom">
    <TD STYLE="width: 90%; text-align: left"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUMMARY</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: right"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-3</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; text-align: left; vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; text-align: left; vertical-align: bottom">
    <TD STYLE="text-align: left"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK FACTORS</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-6</FONT></A></TD></TR>
  <TR STYLE="font-size: 10pt; text-align: left; vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font-size: 10pt">
    <TD STYLE="text-align: left"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">USE OF PROCEEDS AND HEDGING</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-17</FONT></A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font-size: 10pt">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font-size: 10pt">
    <TD STYLE="text-align: left"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION OF THE ARNs</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-18</FONT></A></TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font-size: 10pt">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font-size: 10pt">
    <TD STYLE="text-align: left"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SUPPLEMENTAL PLAN OF DISTRIBUTION</FONT></A></TD>
    <TD STYLE="text-align: right"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PS-31</FONT></A></TD></TR>
  </TABLE></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">_______________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">We have not authorized anyone to provide any information
other than that contained or incorporated by reference in the applicable term sheet, this product supplement or the accompanying prospectus
supplement or prospectus with respect to the ARNs offered by the applicable term sheet or with respect to Barclays Bank PLC. We take no
responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. The applicable
term sheet, together with this product supplement and the accompanying prospectus supplement and prospectus, will contain the terms of
the ARNs and will supersede all other prior or contemporaneous oral statements as well as any other written materials, including preliminary
or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, fact sheets, brochures or
other educational materials of Barclays Bank PLC. The information in each applicable term sheet, this product supplement and the accompanying
prospectus supplement and prospectus may be accurate only as of the date of that document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left; text-indent: 35pt">The
ARN<FONT STYLE="text-transform: none">s</FONT> are not appropriate for all investors and involve a number of risks and important legal
and tax consequences that should be discussed with your professional advisOrs. You should be aware that the regulations of Financial Industry
Regulatory Authority, Inc., or &ldquo;FINRA,&rdquo; and the laws of certain jurisdictions (including regulations and laws that require
brokers to ensure that investments are suitable for their customers) may limit the availability of the ARN<FONT STYLE="text-transform: none">s</FONT>.
The applicable term sheet, this product supplement and the accompanying prospectus supplement and prospectus do not constitute an offer
to sell or a solicitation of an offer to buy the ARN<FONT STYLE="text-transform: none">s</FONT> under any circumstances in which that
offer or solicitation is unlawful.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: left; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">ARNs<SUP>&reg;</SUP> and &ldquo;Accelerated Return
Notes<SUP>&reg;</SUP>&rdquo; are registered service marks of Bank of America Corporation, the parent corporation of BofAS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<DIV STYLE="padding: 5pt; border: Black 1pt solid">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_001"></A>SUMMARY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information in this &ldquo;Summary&rdquo; section
is qualified in its entirety by the more detailed explanation set forth elsewhere in this product supplement and the accompanying prospectus
supplement and prospectus, as well as the applicable term sheet.&nbsp;&nbsp;Neither we nor BofAS have authorized any other person to provide
you with any information other than that contained or incorporated by reference in this product supplement, the accompanying prospectus
supplement and prospectus, and the applicable term sheet. Neither we nor BofAS take any responsibility for, and can provide no assurance
as to the reliability of, any other information that others may give you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Key Terms:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font-size: 10pt; text-indent: 0in"><B>General:</B></TD>
    <TD STYLE="width: 83%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><FONT STYLE="background-color: white">The ARNs are
    unsecured and unsubordinated obligations of Barclays Bank PLC, and are not covered by the U.K. Financial Services Compensation Scheme
    or insured or guaranteed by the FDIC or any other governmental agency of the United States, the United Kingdom or any other jurisdiction.&nbsp;&nbsp;They
    rank <I>pari passu</I>, without any preference among themselves, with all our other outstanding unsecured and unsubordinated obligations,
    present and future, except those obligations as are preferred by operation of law.<B>&nbsp;&nbsp;</B></FONT><B>Any payments due on the
    ARNs, including any repayment of principal, are subject to our credit risk and to the exercise of any U.K. Bail-in Power by any relevant
    U.K. resolution authority (as described in the accompanying prospectus supplement).</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The return on the ARNs will be based on the performance
    of a Market Measure and there is no guaranteed return of principal at maturity. Therefore, you may lose all or a significant portion of
    your investment if the value of the Market Measure decreases from the Starting Value to the Ending Value.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Each issue of the ARNs will mature on the date set
    forth in the applicable term sheet.&nbsp;&nbsp;We cannot redeem the ARNs at any earlier date, except under the limited circumstances as
    set forth in the section &ldquo;Description of the ARNs&mdash;Anti-Dilution Adjustments&mdash;Reorganization Events.&rdquo;&nbsp;&nbsp;We
    will not make any payments on the ARNs until maturity, and you will not receive any interest payments.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Market Measure:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The Underlying Stock of a company other than us, the
    agents and our respective affiliates (the <B>&ldquo;Underlying Company&rdquo;</B>) represented either by a class of common equity securities
    registered under the Securities Exchange Act of 1934, as amended (the <B>&ldquo;Exchange Act&rdquo;</B>), or by ADRs, which are securities
    issued through depositary arrangements and registered under the Exchange Act and which represent shares of non-U.S. equity securities
    (in which case, if an Underlying Stock is an ADR, the &ldquo;Underlying Company&rdquo; of that Underlying Stock refers to the issuer of
    the shares underlying that ADR). The Market Measure will be set forth in the applicable term sheet.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The Market Measure may consist of a group, or &ldquo;<B>Basket</B>,&rdquo;
    of two or more Underlying Stocks.&nbsp;&nbsp;We refer to each Underlying Stock included in any Basket as a &ldquo;<B>Basket Stock</B>.&rdquo;&nbsp;&nbsp;If
    the Market Measure to which your ARNs are linked is a Basket, the Basket Stocks will be set forth in the applicable term sheet.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Market Measure Performance:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The performance of the Market Measure will be measured
    according to the percentage change of the Market Measure from its Starting Value to its Ending Value.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Unless otherwise specified in the applicable term
    sheet:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The &ldquo;<B>Starting Value</B>&rdquo; will be the
    price of the Underlying Stock on the date when the ARNs are priced for initial sale to the public (the &ldquo;<B>pricing date</B>&rdquo;),
    determined as set</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="padding: 5pt; border: Black 1pt solid">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="width: 83%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">forth in the applicable term sheet.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">If the Market Measure consists of a Basket, the Starting
    Value will be equal to 100.&nbsp;&nbsp;See &ldquo;Description of the ARNs&mdash;Basket Market Measures.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The &ldquo;<B>Ending Value</B>&rdquo; will equal the
    Closing Market Price (as defined below) of the Underlying Stock on the calculation day <I>multiplied by </I>its Price Multiplier (as defined
    below) on that day.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">If the Market Measure consists of a Basket, the Ending
    Value will be determined as described in &ldquo;Description of the ARNs&mdash;Basket Market Measures&mdash;Ending Value of the Basket.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">If a Market Disruption Event (as defined below) occurs
    and is continuing on the scheduled calculation day, or if certain other events occur, the calculation agent will determine the Ending
    Value as set forth in the section &ldquo;Description of the ARNs&mdash;The Starting Value and the Ending Value&mdash;Ending Value&rdquo;
    or &ldquo;&mdash;Basket Market Measures &mdash;Ending Value of the Basket.&rdquo;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Participation Rate:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">The rate at which investors participate in any increase in the value of the Market Measure, as calculated below.&nbsp;&nbsp;The Participation Rate will be 300% for the ARNs, unless otherwise set forth in the applicable term sheet.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Capped Value:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">The maximum Redemption Amount.&nbsp;&nbsp;Any positive return on the ARNs will be limited to the return represented by the Capped Value specified in the applicable term sheet.&nbsp;&nbsp;We will determine the applicable Capped Value on the pricing date of each issue of the ARNs.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Price Multiplier:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">Unless otherwise set forth in the applicable term sheet, the &ldquo;<B>Price Multiplier</B>&rdquo; for an Underlying Stock will be 1, and will be subject to adjustment for certain corporate events relating to that Underlying Stock described below under &ldquo;Description of the ARNs&mdash;Anti-Dilution Adjustments.&rdquo;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><BR STYLE="clear: both">
<B>Redemption Amount at Maturity:</B></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">At maturity, you will receive a Redemption Amount
    that is greater than the principal amount if the value of the Market Measure increases from the Starting Value to the Ending Value.&nbsp;&nbsp;However,
    in no event will the Redemption Amount exceed the Capped Value. If the value of the Market Measure does not change from the Starting Value
    to the Ending Value, you will receive a Redemption Amount that equals the principal amount. If the value of the Market Measure decreases
    from the Starting Value to the Ending Value, you will be subject to 1-to-1 downside exposure to that decrease and will receive a Redemption
    Amount that is less than the principal amount.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Any payments due on the ARNs, including any repayment
    of principal, are subject to our credit risk as issuer of the ARNs and the risk of exercise of any U.K. Bail-in Power.</B></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">The Redemption Amount, denominated in U.S. dollars,
will be calculated as follows:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;<IMG SRC="image_001.jpg" ALT=""></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"></P></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

</DIV>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<DIV STYLE="border: Black 1pt solid; padding: 5pt">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font-size: 10pt; text-indent: 0in"><B>Principal at</B> <B> Risk:</B></TD>
    <TD STYLE="width: 83%; font-size: 10pt; text-indent: 0in"> You may lose all or a significant portion of the principal amount of the ARNs.&nbsp;&nbsp;Further, if you sell your ARNs prior to maturity in the secondary market (if any), the market value per ARN may be less than the price that you paid for the ARNs.</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 17%; font-size: 10pt; text-indent: 0in"><B>Calculation Agents:</B></TD>
    <TD STYLE="width: 83%; font-size: 10pt; text-indent: 0in">The calculation agents will make all determinations associated with the ARNs.&nbsp;&nbsp;Unless otherwise set forth in the applicable term sheet, we or one of our affiliates may act as the calculation agent, or we may appoint BofAS or one of its affiliates to act as the calculation agent for the ARNs.&nbsp;&nbsp;Alternatively, we (or one of our affiliates) and BofAS (or one of its affiliates) may act as joint calculation agents for the ARNs. See the section entitled &ldquo;Description of the ARNs&mdash;Role of the Calculation Agent.&rdquo;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Agents:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">BofAS and one or more of its affiliates will act as our agents in connection with each offering of the ARNs and will receive an underwriting discount based on the number of units of the ARNs sold.&nbsp;&nbsp;None of the agents is your fiduciary or advisor solely as a result of the making of any offering of the ARNs, and you should not rely upon this product supplement, the applicable term sheet, or the accompanying prospectus supplement or prospectus as investment advice or a recommendation to purchase the ARNs.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>Listing:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">Unless otherwise specified in the applicable term sheet, the ARNs will not be listed on a securities exchange or quotation system.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-indent: 0in"><B>U.K. Bail-in Power:</B></TD>
    <TD STYLE="font-size: 10pt; text-indent: 0in">Notwithstanding and to the exclusion of any other terms of the ARNs or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner of the ARNs (or the trustee on behalf of the holders of the ARNs), by acquiring the ARNs, each holder or beneficial owner of the ARNs, acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution authority.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This product supplement relates only to the ARNs
and does not relate to any Underlying Stock that comprises the Market Measure described in any applicable term sheet.&nbsp;&nbsp;You should
read carefully the entire prospectus, prospectus supplement and this product supplement, together with the applicable term sheet, to understand
fully the terms of your ARNs, as well as the tax and other considerations important to you in making a decision about whether to invest
in any ARNs.&nbsp;&nbsp;In particular, you should review carefully the sections in this product supplement and the accompanying prospectus
supplement entitled &ldquo;Risk Factors,&rdquo; which highlight a number of risks of an investment in the ARNs, to determine whether an
investment in the ARNs is appropriate for you.&nbsp;&nbsp;Additional risk factors may be set forth in the applicable term sheet. If information
in this product supplement is inconsistent with the accompanying prospectus supplement or prospectus, this product supplement will supersede
those documents.&nbsp;&nbsp;However, if information in any applicable term sheet is inconsistent with information in this product supplement,
that term sheet will supersede this product supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Neither we nor any agent is making an offer to sell
the ARNs in any jurisdiction where the offer or sale is not permitted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Certain capitalized terms used and not defined in
this product supplement have the meanings ascribed to them in the accompanying prospectus supplement or prospectus.&nbsp;&nbsp;Unless
otherwise indicated or unless the context requires otherwise, all references in this product supplement to &ldquo;we,&rdquo; &ldquo;us,&rdquo;
&ldquo;our,&rdquo; or similar references are to Barclays Bank PLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">You are urged to consult with your own attorneys
and business and tax advisors before making a decision to purchase any ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_002"></A>RISK FACTORS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Your investment in the ARNs is subject to investment
risks, many of which differ from those of a conventional debt security.&nbsp;&nbsp;Your decision to purchase the ARNs should be made only
after carefully considering the risks, including those discussed below, together with the risk information contained in the accompanying
prospectus supplement and in the applicable term sheet, in light of your particular circumstances.&nbsp;&nbsp;The ARNs are not an appropriate
investment for you if you are not knowledgeable about the material terms of the ARNs or investments in equity or equity-based securities
in general.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><U>Structure-related Risks </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Your investment may result in a loss; there is
no guaranteed return of principal.&nbsp;&nbsp;There is no fixed principal repayment amount on the ARNs at maturity.&nbsp;&nbsp;</B>The
return on the ARNs will be based on the performance of the Market Measure. If the Ending Value is less than the Starting Value, then you
will receive a Redemption Amount at maturity that will be less than, and possibly significantly less than, the principal amount of your
ARNs. The Redemption Amount could be zero.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The ARNs do not pay interest, and any return
on the ARNs may be less than the yield on a conventional fixed or floating rate debt security of comparable maturity.</B>&nbsp;&nbsp;There
will be no periodic interest payments on the ARNs as there would be on a conventional fixed-rate or floating-rate debt security having
the same maturity.&nbsp;&nbsp;Any return that you receive on the ARNs may be less than the return you would earn if you purchased a conventional
debt security with the same maturity date.&nbsp;&nbsp;As a result, your investment in the ARNs may not reflect the full opportunity cost
to you when you consider factors, such as inflation, that affect the time value of money.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Payment on the ARNs is subject to our credit
risk, and any actual or perceived changes in our creditworthiness are expected to affect the value of the ARNs</B>.&nbsp;&nbsp;The ARNs
are our senior unsecured debt securities.&nbsp;&nbsp;As a result, your receipt of the Redemption Amount at maturity is dependent upon
our ability to repay our obligations on the maturity date, regardless of whether the Market Measure increases from the Starting Value
to the Ending Value.&nbsp;&nbsp;No assurance can be given as to what our financial condition will be on the maturity date. If we become
unable to meet our financial obligations as they become due, you may not receive any amounts payable under the terms of the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, our credit ratings are an assessment
by ratings agencies of our ability to pay our obligations.&nbsp;&nbsp;Consequently, our perceived creditworthiness and actual or anticipated
decreases in our credit ratings or increases in the spread between the yield on our securities and the yield on U.S. Treasury securities
(the &ldquo;<B>credit spread</B>&rdquo;) prior to the maturity date may adversely affect the market value of the ARNs.&nbsp;&nbsp;However,
because your return on the ARNs depends upon factors in addition to our ability to pay our obligations, such as the value of the Market
Measure, an improvement in our credit ratings will not reduce the other investment risks related to the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Any positive return on your investment will be
limited to the return represented by the Capped Value and may be less than a comparable investment directly in the Market Measure.&nbsp;&nbsp;</B>The
appreciation potential of the ARNs is limited to the Capped Value.&nbsp;&nbsp;You will not receive a Redemption Amount greater than the
Capped Value, regardless of the extent of the increase in the value of the Market Measure.&nbsp;&nbsp;In contrast, a direct investment
in the Market Measure would allow you to receive the full benefit of any appreciation in the value of the Market Measure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, unless otherwise set forth in the applicable
term sheet or in the event of an adjustment as described in this product supplement under &ldquo;Description of the ARNs&mdash;Anti-Dilution
Adjustments,&rdquo; the Ending Value will not reflect the value of any dividends paid, or any distributions made, on any Underlying Stock
or any other rights associated with any Underlying Stock. Thus, any return on the ARNs will not reflect the return you would realize if
you actually owned shares of an Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The Redemption Amount will not reflect changes
in the value of the Market Measure that occur other than on the calculation day.</B>&nbsp;&nbsp;Changes in the value of the Market Measure
during the term of the ARNs other than on the calculation day will not be reflected in the calculation of the Redemption Amount.&nbsp;&nbsp;To
calculate the Redemption Amount, the calculation agent will compare only the Ending Value to the Starting Value.&nbsp;&nbsp;No other values
of the Market Measure will be taken into account.&nbsp;&nbsp;As a result, even if the value of the Market Measure has increased at certain
times during the term of the ARNs, you will receive a Redemption Amount that is less than the principal amount if the Ending Value is
less than the Starting Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>If your ARNs are linked to a Basket, increases
in the prices of one or more of the Basket Stocks may be offset by decreases in the prices of one or more of the other Basket Stocks.</B>&nbsp;&nbsp;The
Market Measure of your ARNs may be a Basket.&nbsp;&nbsp;In such a case, changes in the prices of one or more of the Basket Stocks may
not correlate with changes in the prices of one or more of the other Basket Stocks.&nbsp;&nbsp;The prices of one or more Basket Stocks
may increase, while the prices of one or more of the other Basket Stocks may decrease or not increase as much.&nbsp;&nbsp;Therefore, in
calculating the value of the Market Measure at any time, increases in the price of one Basket Stock may be moderated or wholly offset
by decreases or lesser increases in the prices of one or more of the other Basket Stocks.&nbsp;&nbsp;If the weightings of the applicable
Basket Stocks are not equal, adverse changes in the prices of the Basket Stocks that are more heavily weighted could have a greater impact
upon the value of the Market Measure and, consequently, the return on your ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Any payments on the ARNs are subject to the exercise
of U.K. Bail-in Power by the relevant U.K. resolution authority. </B>Any payments on the ARNs are subject to the exercise of any U.K.
Bail-in Power by any relevant U.K. resolution authority that may result in (i) the reduction or cancellation of all, or a portion, of
the principal amount of, or interest on, or any other amounts payable on, the ARNs; (ii) the conversion of all, or a portion, of the principal
amount of, or interest on, or any other amounts payable on, the ARNs into shares or other securities or other obligations of Barclays
Bank PLC or another person (and the issue to, or conferral on, the holder or beneficial owner of the ARNs of such shares, securities or
obligations); (iii) the cancellation of the ARNs and/or (iv) the amendment or alteration of the maturity of the ARNs, or the amendment
of the amount of interest or any other amounts due on the ARNs, or the dates on which interest or any other amounts become payable, including
by suspending payment for a temporary period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding and to the exclusion of any other
term of the ARNs or any other agreements, arrangements or understandings between Barclays Bank PLC and any holder or beneficial owner
of the ARNs (or the trustee on behalf of the holders of the ARNs), by acquiring the ARNs, each holder or beneficial owner of the ARNs
acknowledges, accepts, agrees to be bound by, and consents to the exercise of, any U.K. Bail-in Power by the relevant U.K. resolution
authority. You are urged to consult the information and the risk factors related to U.K. Bail-in Power set forth in the applicable term
sheet and the accompanying prospectus supplement prior to investing in the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B><U>Valuation- and Market-related Risks</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The estimated value of the ARNs is expected to
be lower than their public offering price. </B>This difference is expected as a result of certain factors, such as the inclusion in the
public offering price of the underwriting discount, an expected hedging-related charge, the estimated profit, if any, that we or any of
our affiliates expect to earn in connection with structuring the ARNs, and the estimated cost which we may incur in hedging our obligations
under the ARNs. If you attempt to sell the ARNs prior to maturity, their market value may be lower than the price you paid for the ARNs
and lower than the estimated value because the secondary market prices take into consideration the levels at which our debt securities
trade in the secondary market but do not take into account such fees, charges and other amounts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Our estimated value of the ARNs is based on subjective
assumptions which may not materialize and which may prove to be inaccurate. </B>The estimated value of the ARNs, which will be set forth
in the applicable term sheet, is based on our internal pricing models.&nbsp;&nbsp;Our internal pricing models take into account a number
of variables and are based on a number of subjective assumptions, which may or may not materialize, typically including volatility, interest
rates, and our internal funding rates.&nbsp;&nbsp;These variables and assumptions are not evaluated or verified on an independent basis
and may prove to be inaccurate.&nbsp;&nbsp;Different pricing models and assumptions of different financial institutions could provide
valuations for the ARNs that are different from our estimated value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The estimated value is expected to be based on
a number of variables, including volatility, interest rates and our internal funding rates.</B>&nbsp;&nbsp;Our internal funding rates
may vary from the levels at which our benchmark debt securities trade in the secondary market.&nbsp;&nbsp;As a result of this difference,
the estimated value set forth in the applicable term sheet may be lower if that estimated value was based on the levels at which our benchmark
debt securities trade in the secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The estimated value of the ARNs will not be a
prediction of the prices at which BofAS or its affiliates, or any of our affiliates or any other third parties, may be willing to purchase
the ARNs from you in secondary market transactions.</B>&nbsp;&nbsp;The price at which you may be able to sell your ARNs in the secondary
market at any time will be influenced by many factors that cannot be predicted, such as market conditions and any bid and ask spread for
similar size trades, and may be substantially less than our estimated value of the ARNs.&nbsp;&nbsp;Any sale prior to the maturity date
could result in a substantial loss to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>We cannot assure you that there will be a trading
market for your ARNs.</B>&nbsp;&nbsp;If a secondary market exists, we cannot predict how the ARNs will trade, or whether that market will
be liquid or illiquid.&nbsp;&nbsp;The development of a trading market for the ARNs will depend on various factors, including our financial
performance and changes in the value of the Market Measure.&nbsp;&nbsp;The number of potential buyers of your ARNs in any secondary market
may be limited.&nbsp;&nbsp;There is no assurance that any party will be willing to purchase your ARNs at any price in any secondary market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We anticipate that one or more of the agents or
their affiliates will act as a market-maker for the ARNs, but none of them is required to do so and may cease to do so at any time.&nbsp;&nbsp;Any
price at which an agent or its affiliates may bid for, offer, purchase, or sell any ARNs may be higher or lower than the applicable public
offering price, and that price may differ from the values determined by pricing models that it may use, whether as a result of dealer
discounts, mark-ups, or other transaction costs.&nbsp;&nbsp;These bids, offers, or transactions may adversely affect the prices, if any,
at which the ARNs might otherwise trade in the market.&nbsp;&nbsp;In addition, if at any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">time any entity were to cease acting as a market-maker
for any issue of the ARNs, it is likely that there would be significantly less liquidity in that secondary market.&nbsp;&nbsp;In such
a case, the price at which those ARNs could be sold would likely be lower than if an active market existed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise stated in the applicable term sheet,
we will not list the ARNs on any securities exchange or quotation system.&nbsp;&nbsp;Even if an application were made to list your ARNs,
we cannot assure you that the application will be approved or that your ARNs will be listed and, if listed, that they will remain listed
for their entire term.&nbsp;&nbsp;The listing of the ARNs on any securities exchange or quotation system will not necessarily ensure that
a trading market will develop or, if a trading market does develop, that there will be liquidity in the trading market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The ARNs are not designed to be short-term trading
instruments, and if you attempt to sell the ARNs prior to maturity, their market value, if any, will be affected by various factors that
interrelate in complex ways, and their market value may be less than the principal amount.</B>&nbsp;&nbsp;The ARNs are not designed to
be short-term trading instruments. You have no right to have your ARNs redeemed prior to maturity.&nbsp;&nbsp;If you wish to liquidate
your investment in the ARNs prior to maturity, your only option would be to sell them in the secondary market (if any).&nbsp;&nbsp;At
that time, there may be an illiquid market for the ARNs or no market at all.&nbsp;&nbsp;Even if you were able to sell your ARNs, there
are many factors outside of our control that may adversely affect their market value, some of which, but not all, are stated below.&nbsp;&nbsp;These
factors may interact with each other in complex and unpredictable ways, and the impact of any one factor may be offset or magnified by
the effect of another factor.&nbsp;&nbsp;Each of the following paragraphs describes a specific factor&rsquo;s expected impact on the market
value of the ARNs, assuming all other conditions remain constant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Value of the Market Measure.</B>&nbsp;&nbsp;We anticipate that the market value of the ARNs prior to maturity generally will depend
to a significant extent on the value of the Market Measure.&nbsp;&nbsp;In general, it is expected that the market value of the ARNs will
decrease as the value of the Market Measure decreases, and increase as the value of the Market Measure increases.&nbsp;&nbsp;However,
as the value of the Market Measure increases, the market value of the ARNs may decrease or may not increase at the same rate.&nbsp;&nbsp;If
you sell your ARNs when the value of the Market Measure is less than, or not sufficiently above, the Starting Value, then you may receive
less than the principal amount of your ARNs.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">In addition, because the Redemption Amount will not exceed
the applicable Capped Value, we do not expect that the ARNs will trade in any secondary market at a price that is greater than the Capped
Value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Volatility of the Market Measure.</B>&nbsp;&nbsp;Volatility is a measure of the degree of variation in the value of the Market
Measure over a period of time. The volatility of the Market Measure during the term of the ARNs may vary. In addition, an unsettled international
environment and related uncertainties may result in greater market volatility, which may continue over the term of the ARNs.&nbsp;&nbsp;Increases
or decreases in the volatility of the Market Measure may have an adverse impact on the market value of the ARNs.&nbsp;&nbsp;Even if the
value of the Market Measure increases after the applicable pricing date, if you are able to sell your ARNs before their maturity date,
you may receive substantially less than the amount that would be payable at maturity based on that value because of the anticipation that
the value of the Market Measure will continue to fluctuate until the Ending Value is determined.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Economic and Other Conditions Generally.</B>&nbsp;&nbsp;The general economic conditions of the capital markets in the United States,
as well as geopolitical conditions and other financial, political, public health, regulatory and judicial events, natural disasters, acts
of</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">terrorism or war, and related uncertainties that affect stock
markets generally, may adversely affect the value of the Market Measure and the market value of the ARNs. If an Underlying Stock is an
ADR, the value of your ARNs may also be adversely affected by similar events in the markets of the relevant foreign country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.1in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Interest Rates.</B>&nbsp;&nbsp;We expect that changes in interest rates will affect the market value of the ARNs.&nbsp;&nbsp;In
general, if U.S. interest rates increase, we expect that the market value of the ARNs will decrease.&nbsp;&nbsp;In general, we expect
that the longer the amount of time that remains until maturity, the more significant the impact of these changes will be on the value
of the ARNs. The level of interest rates also may affect the U.S. economy and any applicable market outside of the United States, and,
in turn, the value of the Market Measure, and, thus, the market value of the ARNs may be adversely affected.&nbsp;&nbsp;If an Underlying
Stock is an ADR, the level of interest rates in the relevant foreign country may affect the economy of that foreign country and, in turn,
the value of the ADR, and, thus, the market value of the ARNs may be adversely affected.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Dividend Yields.</B>&nbsp;&nbsp;In general, if the cumulative dividend yield on an Underlying Stock increases, we anticipate that
the market value of the ARNs will decrease.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Our Financial Condition and Creditworthiness.&nbsp;&nbsp;</B>Our actual and perceived creditworthiness, including any increase
in our credit spreads and any actual or anticipated decreases in our credit ratings, may adversely affect the market value of the ARNs.
In general, we expect the longer the amount of time that remains until maturity, the more significant the impact will be on the value
of the ARNs.&nbsp;&nbsp;However, a decrease in our credit spreads or an improvement in our credit ratings will not necessarily increase
the market value of the ARNs.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 9pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Time to Maturity.</B>&nbsp;&nbsp;There may be a disparity between the market value of the ARNs prior to maturity and their value
at maturity. This disparity is often called a time &ldquo;value,&rdquo; &ldquo;premium,&rdquo; or &ldquo;discount,&rdquo; and reflects
expectations concerning the value of the Market Measure prior to the maturity date. As the time to maturity decreases, this disparity
will likely decrease, such that the market value of the ARNs will approach the expected Redemption Amount to be paid at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in"><B><U>Conflict-related Risks </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Trading and hedging activities by us, the agents
and our respective affiliates may adversely affect your return on the ARNs and their market value.&nbsp;&nbsp;</B>We, the agents and our
other respective affiliates may buy or sell shares of any Underlying Stock, or futures or options contracts or exchange-traded instruments
on any Underlying Stock, or other listed or over-the-counter derivative instruments linked to any Underlying Stock.&nbsp;&nbsp;We, the
agents or our respective affiliates may execute such purchases or sales for our own or their own accounts, for business reasons, or in
connection with hedging our obligations under the ARNs.&nbsp;&nbsp;These transactions could adversely affect the value of an Underlying
Stock in a manner that could be adverse to your investment in the ARNs.&nbsp;&nbsp;On or before the applicable pricing date, any purchases
or sales by us, the agents or our respective affiliates, or others on our or their behalf (including those for the purpose of hedging
some or all of our anticipated exposure in connection with the ARNs), may affect the value of an Underlying Stock.&nbsp;&nbsp;Consequently,
the value of that Underlying Stock may change subsequent to the pricing date of an issue of the ARNs, which may adversely affect the market
value of the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We, the agents or one or more of our respective
affiliates also expect to engage in hedging activities that could affect the value of an Underlying Stock on the applicable pricing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">date.&nbsp;&nbsp;In addition, these hedging activities,
including the unwinding of a hedge, may decrease the value of an Underlying Stock prior to maturity, including on the calculation day,
and may reduce the Redemption Amount.&nbsp;&nbsp;We, the agents or one or more of our respective affiliates may purchase or otherwise
acquire a long or short position in the ARNs or an Underlying Stock, and may hold or resell the ARNs or an Underlying Stock.&nbsp;&nbsp;For
example, the agents may enter into these transactions in connection with any market making activities in which they engage.&nbsp;&nbsp;We
cannot assure you that these activities will not adversely affect the value of an Underlying Stock, the market value of your ARNs prior
to maturity or the Redemption Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Our trading, hedging and other business activities,
and those of the agents and one or more of our respective affiliates, may create conflicts of interest with you.</B>&nbsp;&nbsp;We, the
agents or one or more of our respective affiliates may engage in trading activities related to an Underlying Stock that are not for your
account or on your behalf.&nbsp;&nbsp;We, the agents or one or more of our respective affiliates also may issue or underwrite other financial
instruments with returns based upon the applicable Market Measure or an Underlying Stock. In addition, in the ordinary course of their
business activities, the agents or their affiliates may hold and trade our or our affiliates&rsquo; debt and equity securities (or related
derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers.
Certain of the agents or their affiliates may also have a lending or other financial relationship with us. In order to hedge such exposure,
the agents or their affiliates may enter into transactions such as the purchase of credit default swaps or the creation of short positions
in our or our affiliates&rsquo; securities, including potentially the ARNs. Any such short positions could adversely affect future trading
prices of the ARNs. These trading and other business activities may present a conflict of interest between your interest in the ARNs and
the interests we, the agents and our respective affiliates may have in our proprietary accounts, in facilitating transactions, including
block trades, for our or their other customers, and in accounts under our or their management.&nbsp;&nbsp;These trading and other business
activities, if they influence the value of the Market Measure or secondary trading in your ARNs, could be adverse to your interests as
a beneficial owner of the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt">We, the agents and our respective affiliates expect
to enter into arrangements or adjust or close out existing transactions to hedge our obligations under the ARNs.&nbsp;&nbsp;We, the agents
or our respective affiliates also may enter into hedging transactions relating to other ARNs or instruments that we or they issue, some
of which may have returns calculated in a manner related to that of a particular issue of the ARNs.&nbsp;&nbsp;We may enter into such
hedging arrangements with one or more of our subsidiaries or affiliates, or with one or more of the agents or their affiliates.&nbsp;&nbsp;Such
a party may enter into additional hedging transactions with other parties relating to the ARNs and the applicable Underlying Stock(s).&nbsp;&nbsp;This
hedging activity is expected to result in a profit to those engaging in the hedging activity, which could be more or less than initially
expected, but could also result in a loss.&nbsp;&nbsp;We, the agents and our respective affiliates will price these hedging transactions
with the intent to realize a profit, regardless of whether the value of the ARNs increases or decreases or whether the Redemption Amount
on the ARNs may be adversely affected. Any profit in connection with such hedging activities will be in addition to any other compensation
that we, the agents and any of our respective affiliates receive for the sale of the ARNs, which creates an additional incentive to sell
the ARNs to you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 42.85pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>There may be potential conflicts of interest
involving the calculation agent, which may be us or an affiliate of ours.&nbsp;&nbsp;We may appoint and remove the calculation agent.</B>&nbsp;&nbsp;We
or one of our affiliates may be the calculation agent or act as joint calculation agent for the ARNs and, as such, will have the sole
discretion to make all determinations regarding the ARNs as described in this product supplement, including determinations regarding the
Starting Value, the Ending Value, the Price Multiplier, the Market Measure, the Closing Market Price,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">the Redemption Amount, any Market Disruption Events,
any anti-dilution adjustments, any successor Underlying Stock, business days, trading days and the calculation day.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under some circumstances, these duties could result
in a conflict of interest between our status as issuer and our or our affiliate&rsquo;s responsibilities as calculation agent.&nbsp;&nbsp;These
conflicts could occur, for instance, in connection with the calculation agent&rsquo;s determination as to whether a Market Disruption
Event has occurred, or in connection with judgments that the calculation agent would be required to make if certain corporate events occur
with respect to an Underlying Stock.&nbsp;&nbsp;See the sections entitled &ldquo;Description of the ARNs&mdash;Market Disruption Events&rdquo;
and &ldquo;&mdash;Anti-Dilution Adjustments.&rdquo;&nbsp;&nbsp;The calculation agent will be required to carry out its duties in good
faith and using its reasonable judgment.&nbsp;&nbsp;However, because we or one of our affiliates may serve as the calculation agent, potential
conflicts of interest could arise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, we may appoint BofAS or one of its
affiliates to act as the calculation agent or as joint calculation agent for the ARNs. As the calculation agent or joint calculation agent,
BofAS or one of its affiliates will have discretion in making various determinations that affect your ARNs.&nbsp;&nbsp;The exercise of
this discretion by the calculation agent could adversely affect the value of your ARNs and may present the calculation agent with a conflict
of interest of the kind described under &ldquo;&mdash;Trading and hedging activities by us, the agents and our respective affiliates may
adversely affect your return on the ARNs and their market value&rdquo; and &ldquo;&mdash;Our trading, hedging and other business activities,
and those of the agents and one or more of our respective affiliates, may create conflicts of interest with you&rdquo; above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Our business activities and those of the agents
relating to an Underlying Company or the ARNs may create conflicts of interest with you.</B>&nbsp;&nbsp;We, the agents and our respective
affiliates, at the time of any offering of the ARNs or in the future, may engage in business with an Underlying Company, including making
loans to, equity investments in, or providing investment banking, asset management, or other services to an Underlying Company, its affiliates,
and its competitors.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with these activities, any of these
entities may receive information about those companies that we will not divulge to you or other third parties.&nbsp;&nbsp;We, the agents
and our respective affiliates have published, and in the future may publish, research reports on one or more of these companies.&nbsp;&nbsp;The
agents may also publish research reports relating to our or our affiliates&rsquo; securities, including the ARNs. This research is modified
from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding
your ARNs.&nbsp;&nbsp;Any of these activities may adversely affect the price of an Underlying Stock and, consequently, the market value
of, and the Redemption Amount on, your ARNs.&nbsp;&nbsp;None of us, the agents or our respective affiliates makes any representation to
any purchasers of the ARNs regarding any matters whatsoever relating to any Underlying Stock or any Underlying Company. Any prospective
purchaser of the ARNs should undertake an independent investigation into an Underlying Stock and an Underlying Company as in its judgment
is appropriate to make an informed decision with respect to an investment in the ARNs. The selection of an Underlying Stock does not reflect
any investment recommendations from us, the agents or our respective affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Underlying Stock-related Risks </U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>You must rely on your own evaluation of the merits
of an investment linked to any applicable Underlying Stock.&nbsp;&nbsp;</B>In the ordinary course of business, we, the agents and our
respective affiliates may have expressed views on expected movements in an Underlying Stock, the applicable financial markets or other
matters that may influence the value of an Underlying Stock and therefore, the value of your ARNs, and may do so in the future.&nbsp;&nbsp;These
views or reports may be communicated to our clients and clients of these entities.&nbsp;&nbsp;However, these views</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">are subject to change from time to time.&nbsp;&nbsp;Moreover,
other professionals who deal in markets relating to an Underlying Stock may at any time have significantly different views from our views
and the views of these entities.&nbsp;&nbsp;For these reasons, you are encouraged to derive information concerning an Underlying Stock
from multiple sources, and you should not rely on our views or the views expressed by these entities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Our offering of the ARNs does not constitute
a recommendation of any Underlying Stock.</B> You should not take our offering of the ARNs as an expression of our views about how any
Underlying Stock will perform in the future or as a recommendation to invest in any Underlying Stock, including through an investment
in the ARNs. As we are part of a global financial institution, we, the agents and our respective affiliates may, and often do, have positions
(both long and short) in the Underlying Stock(s) that may conflict with an investment in the ARNs. You should undertake an independent
determination of whether an investment in the ARNs is appropriate for you in light of your specific investment objectives, risk tolerance
and financial resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>You will have no rights as a security holder
of any Underlying Company, you will have no rights to receive any shares of any Underlying Stock, and you will not be entitled to dividends
or other distributions by any Underlying Company.&nbsp;&nbsp;</B>The ARNs are our debt securities.&nbsp;&nbsp;They are not equity instruments,
shares of stock, or securities of any other issuer.&nbsp;&nbsp;Investing in the ARNs will not make you a holder of any Underlying Stock.&nbsp;&nbsp;You
will not have any voting rights, any rights to receive dividends or other distributions, or any other rights with respect to any Underlying
Stock.&nbsp;&nbsp;As a result, the return on your ARNs may not reflect the return you would realize if you actually owned shares of any
Underlying Stock and received the dividends paid or other distributions made in connection with them.&nbsp;&nbsp;Your ARNs will be paid
in cash and you have no right to receive shares of any Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>If shares of an Underlying Company are also listed
on a foreign exchange, your return may be affected by factors affecting international securities markets.</B>&nbsp;&nbsp;The value of
securities traded outside of the United States may be adversely affected by a variety of factors relating to the relevant securities markets.&nbsp;&nbsp;Factors
which could affect those markets, and therefore the return on your ARNs, include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Market Liquidity and Volatility.</B>&nbsp;&nbsp;The relevant foreign securities markets may be less liquid and/or more volatile
than U.S. or other securities markets and may be affected by market developments in different ways than U.S. or other securities markets.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Political, Economic, and Other Factors.</B>&nbsp;&nbsp;The prices and performance of securities of companies in foreign countries
may be affected by political, economic, financial, public health, natural disasters, acts of terrorism or war, social and other factors
in those regions.&nbsp;&nbsp;Direct or indirect government intervention to stabilize a particular securities market and cross-shareholdings
in companies in the relevant foreign markets may affect prices and the volume of trading in those markets.&nbsp;&nbsp;In addition, recent
or future changes in government, economic, and fiscal policies in the relevant jurisdictions, the possible imposition of, or changes in,
currency exchange laws, or other laws or restrictions, and possible fluctuations in the rate of exchange between currencies, are factors
that could adversely affect the relevant securities markets.&nbsp;&nbsp;The relevant foreign economies may differ from the U.S. economy
in economic factors such as growth of gross national product, rate of inflation, capital reinvestment, resources, and self-sufficiency.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">In particular, many emerging nations are undergoing rapid
change involving the restructuring of economic, political, financial and legal systems. Regulatory and tax</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">environments may be subject to change without review or appeal,
and many emerging markets suffer from underdevelopment of capital markets and tax systems.&nbsp;&nbsp;In addition, in some of these nations,
issuers of the relevant securities face the threat of expropriation of their assets, and/or nationalization of their businesses.&nbsp;&nbsp;The
economic and financial data about some of these countries may be unreliable. Additionally, the accounting, auditing and financial reporting
standards and requirements applicable to companies in foreign countries may differ from those applicable to U.S. reporting companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 20pt"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><B>Publicly Available Information.&nbsp;&nbsp;</B>There is generally less publicly available information about foreign companies than
about U.S. companies that are subject to the reporting requirements of the SEC. In addition, accounting, auditing, and financial reporting
standards and requirements applicable to companies in foreign countries may differ from those applicable to U.S. reporting companies.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>We, the agents and our respective affiliates
do not control any Underlying Company and have not verified any disclosure made by any Underlying Company.</B>&nbsp;&nbsp;We, the agents
or our respective affiliates currently, or in the future may, engage in business with any Underlying Company, and we, the agents or our
respective affiliates may from time to time own securities of any Underlying Company. However, none of us, the agents or any of our respective
affiliates has the ability to control any actions of any Underlying Company or has undertaken any independent review of, or made any due
diligence inquiry with respect to, any Underlying Company. Unless otherwise specified therein, any information in the applicable term
sheet regarding an Underlying Company is derived from publicly available information. You should make your own investigation into any
Underlying Stock and any Underlying Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>An Underlying Company will have no obligations
relating to the ARNs and neither we nor the agents will perform any due diligence procedures with respect to any Underlying Company.</B>&nbsp;&nbsp;An
Underlying Company will not have any financial or legal obligation with respect to the ARNs or the amounts to be paid to you, including
any obligation to take our interests or the interests of holders of the ARNs into consideration for any reason, including when taking
any corporate actions that might adversely affect the value of an Underlying Stock or the value of the ARNs.&nbsp;&nbsp;An Underlying
Company will not receive any of the proceeds from any offering of the ARNs, and will not be responsible for, or participate in, the offering
of the ARNs.&nbsp;&nbsp;No Underlying Company will be responsible for, or participate in, the determination or calculation of any payments
on the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of us, the agents or any of our respective
affiliates will conduct any due diligence inquiry with respect to any Underlying Stock in connection with an offering of the ARNs.&nbsp;&nbsp;None
of us, the agents or any of our respective affiliates has made any independent investigation as to the completeness or accuracy of publicly
available information regarding any Underlying Stock or any Underlying Company or as to the future performance of any Underlying Stock.&nbsp;&nbsp;Any
prospective purchaser of the ARNs should undertake such independent investigation of any Underlying Stock and any Underlying Company as
in its judgment is appropriate to make an informed decision with respect to an investment in the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The historical performance of an Underlying Stock
should not be taken as an indication of its performance during the term of the ARNs. </B>An Underlying Stock may perform better or worse
during the term of the ARNs than it has historically. The historical performance of an Underlying Stock, including any historical performance
set forth in the applicable term sheet, should not be taken as an indication of its future performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The Price Multiplier or other terms of the ARNs
will not be adjusted for all corporate events that could affect an Underlying Company.</B>&nbsp;&nbsp;The Price Multiplier, the Ending
Value, the Redemption Amount, and other terms of the ARNs may be adjusted for the specified corporate events affecting an Underlying Stock,
as described in the section entitled &ldquo;Description of the ARNs&mdash;Anti-Dilution Adjustments.&rdquo;&nbsp;&nbsp;However, these
adjustments do not cover all corporate events that could affect the market price of an Underlying Stock, such as offerings of common shares
for cash or in connection with certain acquisition transactions.&nbsp;&nbsp;The occurrence of any event that does not require the calculation
agent to adjust the Price Multiplier of an Underlying Stock or other terms of the ARNs may adversely affect the Closing Market Price of
that Underlying Stock, the Ending Value, and the Redemption Amount, and, as a result, the market value of the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Risks Relating to Underlying Stocks that Are
ADRs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The value of an ADR may not accurately track
the value of the common shares of the related Underlying Company.&nbsp;&nbsp;</B>If an Underlying Stock is an ADR, each ADR will represent
shares of the relevant Underlying Company.&nbsp;&nbsp;Generally, ADRs are issued under a deposit agreement that sets forth the rights
and responsibilities of the depositary, the Underlying Company and the holders of the ADRs.&nbsp;&nbsp;The trading patterns of the ADRs
will generally reflect the characteristics and valuations of the underlying common shares; however, the value of the ADRs may not completely
track the value of those shares. There are important differences between the rights of holders of ADRs and the rights of holders of the
underlying common shares.&nbsp;&nbsp;In addition, trading volume and pricing on the applicable non-U.S. exchange may, but will not necessarily,
have similar characteristics as the ADRs.&nbsp;&nbsp;For example, certain factors may increase or decrease the public float of the ADRs
and, as a result, the ADRs may have less liquidity or lower market value than the underlying common shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Exchange rate movements may adversely impact
the value of an Underlying Stock that is an ADR.&nbsp;&nbsp;</B>If an Underlying Stock is an ADR, the market price of that Underlying
Stock will generally track the U.S. dollar value of the market price of its underlying common shares.&nbsp;&nbsp;Therefore, if the value
of the related foreign currency in which the underlying common shares are traded decreases relative to the U.S. dollar, the market price
of that Underlying Stock may decrease while the market price of its underlying common shares remains stable or increases, or does not
decrease to the same extent.&nbsp;&nbsp;As a result, changes in, and the volatility of, the exchange rates between the U.S. dollar and
the relevant non-U.S. currency could have an adverse impact on the value of that Underlying Stock and consequently, the value of your
ARNs and the Redemption Amount on the ARNs.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Adverse trading conditions in the applicable
non-U.S. market may negatively affect the value of an Underlying Stock that is an ADR.&nbsp;&nbsp;</B>Holders of an Underlying Company&rsquo;s
ADRs may usually surrender the ADRs in order to receive and trade the underlying common shares.&nbsp;&nbsp;This provision permits investors
in the ADRs to take advantage of price differentials between markets.&nbsp;&nbsp;However, this provision may also cause the market prices
of the applicable Underlying Stock to more closely correspond with the values of the common shares in the applicable non-U.S. markets.&nbsp;&nbsp;As
a result, a market outside of the United States for the underlying common shares that is not liquid may also result in an illiquid market
for the ADRs, which may negatively impact the value of such ADRs and, consequently, the value of your ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Delisting of an Underlying Stock that is an ADR
may adversely affect the value of the ARNs.&nbsp;&nbsp;</B>If an Underlying Stock that is an ADR is no longer listed or admitted to trading
on a U.S. securities exchange registered under the Exchange Act, or if the ADR facility between the Underlying Company and the ADR depositary
is terminated for any reason, the applicable Underlying Stock will be deemed to be the Underlying Company&rsquo;s common shares rather
than the ADRs, and the calculation agent will determine the price of that Underlying Stock by reference to those common shares, as described
below under &ldquo;Description of the ARNs&mdash;Delisting of ADRs or Termination of ADR Facility.&rdquo; Replacing the original ADRs
with the underlying common shares may adversely affect the value of the ARNs and the Redemption Amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
Risk Factors Relating to</FONT> the <FONT STYLE="font-family: Times New Roman, Times, Serif">Applicable Market Measure</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The applicable term sheet may set forth additional
risk factors as to the Market Measure or an Underlying Stock that you should review prior to purchasing the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Tax-related Risks </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>The U.S. federal income tax consequences of an
investment in the ARNs are uncertain.</B> There is no direct legal authority regarding the proper U.S. federal income tax treatment of
the ARNs and we do not plan to request a ruling from the Internal Revenue Service (the &ldquo;<B>IRS</B>&rdquo;). Consequently, significant
aspects of the tax treatment of the ARNs are uncertain, and the IRS or a court might not agree with the treatment of the ARNs as described
in the applicable term sheet and under the sections entitled &ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences
to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo; and &ldquo;&mdash;Tax Consequences to Non-U.S. Holders&rdquo;
in the accompanying prospectus supplement. If the IRS were successful in asserting an alternative treatment, the tax consequences of your
ownership and disposition of the ARNs could be materially and adversely affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The U.S. Treasury Department (&ldquo;<B>Treasury</B>&rdquo;)
and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo;
and similar financial instruments and have indicated that such transactions may be the subject of future regulations or other guidance.
In addition, members of the U.S. Congress (&ldquo;<B>Congress</B>&rdquo;) have proposed legislative changes to the tax treatment of derivative
contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and
adversely affect the tax consequences of an investment in the ARNs, possibly with retroactive effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>You should review the discussion in the applicable
term sheet regarding U.S. federal income tax consequences of an investment in the ARNs, as well as the discussion under the sections entitled
&ldquo;Material U.S. Federal Income Tax Consequences&mdash;Tax Consequences to U.S. Holders&mdash;Notes Treated as Prepaid Forward Contracts&rdquo;
and &ldquo;&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying prospectus supplement, and consult your tax advisor
regarding the U.S. federal tax consequences of an investment in the ARNs as well as tax consequences arising under the laws of any state,
local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_003"></A>USE OF PROCEEDS
AND HEDGING</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will use the net proceeds we receive from each
sale of the ARNs for the purposes described in the accompanying prospectus supplement under &ldquo;Use of Proceeds and Hedging.&rdquo;&nbsp;&nbsp;In
addition, we expect that we or our affiliates may use a portion of the net proceeds to hedge our obligations under the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_004"></A>DESCRIPTION OF THE
ARN<FONT STYLE="text-transform: none">s</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">General</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each issue of the ARNs will be part of a series
of medium-term notes entitled &ldquo;Global Medium-Term Notes, Series A&rdquo; that will be issued under the senior debt securities indenture,
as amended and supplemented from time to time.&nbsp;&nbsp;The senior debt securities indenture is described more fully in the accompanying
prospectus supplement and prospectus.&nbsp;&nbsp;The following description of the ARNs supplements and, to the extent it is inconsistent
with, supersedes the description of the general terms and provisions of the ARNs and debt securities set forth under the headings &ldquo;Terms
of the Notes&rdquo; in the prospectus supplement and &ldquo;Description of Debt Securities&rdquo; in the prospectus.&nbsp;&nbsp;These
documents should be read in connection with this product supplement and the applicable term sheet. The provisions set forth under &ldquo;Terms
of the Notes&mdash;Valuation Dates, Review Dates, Determination Dates, Observation Dates, Calculation Dates and Averaging Dates,&rdquo;
&ldquo;Terms of the Notes&mdash;Calculations and Calculation Agent,&rdquo; &ldquo;Terms of the Notes&mdash;Change-in-Law Events,&rdquo;
&ldquo;Terms of the Notes&mdash;Default Amount&mdash;Determination of Default Amount,&rdquo; &ldquo;Terms of the Notes&mdash;Default Amount&mdash;Default
Quotation Period,&rdquo; &ldquo;Terms of the Notes&mdash;Default Amount&mdash;Qualified Financial Institutions&rdquo; and &ldquo;Reference
Assets&rdquo; in the accompanying prospectus supplement are not applicable to the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The maturity date of the ARNs and the aggregate
principal amount of each issue of the ARNs will be stated in the applicable term sheet. If the scheduled maturity date is not a business
day, we will make the required payment on the next business day, and no interest will accrue as a result of such delay. Unless otherwise
specified in the applicable term sheet, a &ldquo;<B>business day</B>&rdquo; is any day other than a day on which banking institutions
in New York, New York are authorized or required by law, regulation or executive order to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will not pay interest on the ARNs. The ARNs do
not guarantee the return of principal at maturity. The ARNs will be payable only in U.S. dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Prior to the maturity date, the ARNs are not redeemable
by us, except under the limited circumstances as set forth in the section &ldquo;&mdash;Anti-Dilution Adjustments&mdash;Reorganization
Events,&rdquo; or repayable at the option of any holder.&nbsp;&nbsp;The ARNs are not subject to any sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will issue the ARNs in denominations of whole
units.&nbsp;&nbsp;Unless otherwise set forth in the applicable term sheet, each unit will have a principal amount of $10.&nbsp;&nbsp;The
CUSIP number for each issue of the ARNs will be set forth in the applicable term sheet.&nbsp;&nbsp;You may transfer the ARNs only in whole
units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any payments due on the ARNs, including any repayment
of principal, are subject to our credit risk and to the exercise of any U.K. Bail-in Power by any relevant U.K. resolution authority (as
described in the accompanying prospectus supplement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment at Maturity</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At maturity, subject to our credit risk as issuer
of the ARNs, you will receive a Redemption Amount, denominated in U.S. dollars.&nbsp;&nbsp;Unless otherwise specified in the applicable
term sheet, the &ldquo;<B>Redemption Amount</B>&rdquo; will be calculated as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the Ending Value is greater than the Starting Value, then the Redemption Amount will equal:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt"><B><IMG SRC="image_002.jpg" ALT="">&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt">The Redemption Amount will
not exceed a &ldquo;<B>Capped Value</B>&rdquo; set forth in the applicable term sheet.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>If the Ending Value is less than or equal to the Starting Value, then the Redemption Amount will equal:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-weight: normal">The Redemption
Amount will not be less than zero.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.3pt">Your participation in any upside performance of
the Market Measure underlying your ARNs will also be impacted by the Participation Rate.&nbsp;&nbsp;The &ldquo;<B>Participation Rate</B>&rdquo;
will be 300% for the ARNs unless otherwise set forth in the applicable term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.3pt">Each applicable term sheet will provide examples
of the Redemption Amounts based on a range of hypothetical Ending Values.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The applicable term sheet will set forth information
as to the applicable Market Measure, including information as to the historical prices of the Underlying Stock(s).&nbsp;&nbsp;However,
historical prices of an Underlying Stock are not indicative of its future performance or the performance of your ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An investment in the ARNs does not entitle you to
any ownership interest in or any other rights with respect to any Underlying Company or any Underlying Stock, including any voting rights
in any Underlying Stock, nor dividends paid or other distributions made by any Underlying Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Underlying Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any information regarding an Underlying Stock or
an Underlying Company will be derived from publicly available documents. Any Underlying Stock will be registered under the Exchange Act.&nbsp;&nbsp;Information
provided to or filed with the SEC by any Underlying Company can be located at the SEC&rsquo;s facilities or through the SEC&rsquo;s website,
www.sec.gov.&nbsp;&nbsp;None of us, the agents or any of our respective affiliates will have independently verified the accuracy or completeness
of any of the information or reports of an Underlying Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The selection of an Underlying Stock is not a recommendation
to buy or sell that Underlying Stock.&nbsp;&nbsp;None of us, the agents or any of our respective subsidiaries or affiliates makes any
representation to any purchaser of the ARNs as to the performance of any Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Starting Value and the Ending Value</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Starting Value</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specified in the applicable term
sheet, the &ldquo;<B>Starting Value</B>&rdquo; will be the price of the Underlying Stock on the pricing date, determined as set forth
in the applicable term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Market Measure consists of a Basket, the
Starting Value will be equal to 100.&nbsp;&nbsp;See &ldquo;&mdash;Basket Market Measures.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Ending Value</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specified in the applicable term
sheet, the &ldquo;<B>Ending Value</B>&rdquo; will equal the Closing Market Price of the Underlying Stock on the calculation day <I>multiplied
by</I> its Price Multiplier on that day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Market Measure consists of a Basket, the
Ending Value of the Basket will be determined as described in &ldquo;&mdash;Basket Market Measures&mdash;Ending Value of the Basket.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;<B>calculation day</B>&rdquo; means a
trading day shortly before the maturity date. The calculation day will be set forth in the applicable term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A &ldquo;<B>trading day</B>&rdquo; means a day on
which trading is generally conducted (or was scheduled to have been generally conducted, but for the occurrence of a Market Disruption
Event) on the New York Stock Exchange (the &ldquo;<B>NYSE</B>&rdquo;), The Nasdaq Stock Market, the Chicago Board Options Exchange, and
in the over-the-counter market for equity securities in the United States, or any successor exchange or market, or in the case of a security
traded on one or more non-U.S. securities exchanges or markets, on the principal non-U.S. securities exchange or market for such security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;<B>Closing Market Price</B>&rdquo; for
one share of an Underlying Stock (or one unit of any other security for which a Closing Market Price must be determined) on any trading
day means any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the Underlying Stock (or such other security) is listed or admitted to trading on a U.S. national securities exchange, the last
reported sale price, regular way (or, in the case of The Nasdaq Stock Market, the official closing price), of the principal trading session
on that day on the principal U.S. securities exchange registered under the Exchange Act on which the Underlying Stock (or such other security)
is listed or admitted to trading;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the Underlying Stock (or such other security) is not listed or admitted to trading on any U.S. national securities exchange but
is included in any other U.S. national market system, the last reported sale price, regular way, of the principal trading session on that
day on the U.S. national market system that is the primary market for the trading of that Underlying Stock (or such other security);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the Underlying Stock (or such other security) is issued by a foreign issuer and its Closing Market Price cannot be determined as
set forth in the two bullet points above, and the Underlying Stock (or such other security) is listed or admitted to trading on a non-U.S.
securities exchange or market, the last reported sale price, regular way, of the principal trading session on that day on the primary
non-U.S. securities exchange or market on which the Underlying Stock (or such other security) is listed or admitted to trading (converted
to U.S. dollars using such exchange rate as the calculation agent, in its sole discretion, determines to be commercially reasonable);
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>if the Closing Market Price cannot be determined as set forth in the prior bullets, the mean, as determined by the calculation agent,
of the bid prices for the Underlying Stock (or such other security) obtained from as many dealers in that security (which may include
us, BofAS and/or any of our respective affiliates), but not exceeding three, as</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">will make the bid prices available to the
calculation agent. If no such bid price can be obtained, the Closing Market Price will be determined (or, if not determinable, estimated)
by the calculation agent in its sole discretion in a commercially reasonable manner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the scheduled calculation day is not a trading
day or there is a Market Disruption Event on the scheduled calculation day with respect to an Underlying Stock, the calculation day will
be the immediately succeeding trading day during which no Market Disruption Event occurs or is continuing; <I>provided</I> that the Closing
Market Price of that Underlying Stock will be determined (or, if not determinable, estimated) by the calculation agent in a manner which
the calculation agent considers commercially reasonable under the circumstances on a date no later than the second scheduled trading day
prior to the maturity date, regardless of the occurrence of a Market Disruption Event or non-trading day on that day, and such day will
be deemed to be the calculation day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise set forth in the applicable term
sheet, for any applicable day under the terms of the ARNs, the value of an Underlying Stock will be determined by multiplying its Closing
Market Price on that day by its <B>&ldquo;Price Multiplier&rdquo;</B> on that day. The initial Price Multiplier for an Underlying Stock
will be one, unless otherwise set forth in the applicable term sheet. The Price Multiplier for an Underlying Stock will be subject to
adjustment for certain corporate events relating to that Underlying Stock as described below under &ldquo;&mdash;Anti-Dilution Adjustments.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Market Disruption Events</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As to any Underlying Stock (or any &ldquo;<B>successor
Underlying Stock</B>,&rdquo; which is the common equity securities or the ADRs of a Successor Entity (as defined below)), a &ldquo;<B>Market
Disruption Event</B>&rdquo; means one or more of the following events, as determined by the calculation agent in its sole discretion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25pt"></TD><TD STYLE="width: 25pt">(A)</TD><TD>the suspension of or material limitation on trading, in each case, for more than two consecutive hours of trading, or during the one-half
hour period preceding the close of trading, of the shares of the Underlying Stock (or any successor Underlying Stock) on the primary exchange
where such shares trade, as determined by the calculation agent (without taking into account any extended or after-hours trading session);
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 25pt"></TD><TD STYLE="width: 25pt">(B)</TD><TD>the suspension of or material limitation on trading, in each case, for more than two consecutive hours of trading, or during the one-half
hour period preceding the close of trading, on the primary exchange that trades options contracts or futures contracts related to the
shares of the Underlying Stock (or any successor Underlying Stock) as determined by the calculation agent (without taking into account
any extended or after-hours trading session), in options contracts or futures contracts related to the shares of the Underlying Stock
(or any successor Underlying Stock).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">For the purpose of determining whether a Market Disruption
Event as to any Underlying Stock has occurred:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 35pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48.9pt"></TD><TD STYLE="width: 24.5pt">(1)</TD><TD>a limitation on the hours in a trading day and/or number of days of trading will not constitute a Market Disruption Event if it results
from an announced change in the regular business hours of the relevant exchange;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48.9pt"></TD><TD STYLE="width: 24.5pt">(2)</TD><TD>a decision to permanently discontinue trading in the shares of the Underlying Stock (or any successor Underlying Stock) or the relevant
futures or options contracts relating to such shares will not constitute a Market Disruption Event;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48.9pt"></TD><TD STYLE="width: 24.5pt">(3)</TD><TD>a suspension in trading in a futures or options contract on the shares of the&nbsp;&nbsp;Underlying Stock (or any successor Underlying
Stock), by a major securities market by reason of (a) a price change violating limits set by that securities market, (b) an imbalance
of orders relating to those contracts, or (c) a disparity in bid and ask quotes relating to those contracts, will each constitute a suspension
of or material limitation on trading in futures or options contracts relating to the Underlying Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 48.95pt"></TD><TD STYLE="width: 24.5pt">(4)</TD><TD>subject to paragraph (3) above, a suspension of or material limitation on trading on the relevant exchange will not include any time
when that exchange is closed for trading under ordinary circumstances; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 49.7pt"></TD><TD STYLE="width: 22.3pt">(5)</TD><TD>for the purpose of clause (A) above, any limitations on trading during significant market fluctuations under NYSE Rule 80B, or any
applicable rule or regulation enacted or promulgated by the NYSE or any other self-regulatory organization or the SEC of similar scope
as determined by the calculation agent, will be considered &ldquo;material.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Anti-Dilution Adjustments</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As to any Underlying Stock (which, for purposes
of this section, includes any successor Underlying Stock), the calculation agent, in its sole discretion, may adjust the Price Multiplier
(and as a result, the Ending Value), and any other terms of the ARNs (such as the Starting Value), if an event described below occurs
after the pricing date and on or before the calculation day and if the calculation agent determines that such an event has a dilutive
or concentrative effect on the theoretical value of the shares of the applicable Underlying Stock (or any successor Underlying Stock).&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Price Multiplier for an Underlying Stock resulting
from any of the adjustments specified below will be rounded to the eighth decimal place with five one-billionths being rounded upward.
No adjustments to the Price Multiplier will be required unless the adjustment would require a change of at least 0.1% in the Price Multiplier
then in effect.&nbsp;&nbsp;Any adjustment that would require a change of less than 0.1% in the Price Multiplier which is not applied at
the time of the event may be reflected at the time of any subsequent adjustment that would require an adjustment of the Price Multiplier.
The required adjustments specified below do not cover all events that could affect an Underlying Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No adjustments to the Price Multiplier for any Underlying
Stock or any other terms of the ARNs will be required other than those specified below. However, the calculation agent may, at its sole
discretion, make additional adjustments or adjustments that differ from those described herein to the Price Multiplier or any other terms
of the ARNs, including the maturity date and the method of determining the payment on the ARNs, to reflect changes to an Underlying Stock
if the calculation agent determines that the adjustment is appropriate to ensure an equitable result.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The calculation agent will be solely responsible
for the determination of any adjustments to the Price Multiplier for any Underlying Stock or any other terms of the ARNs and of any related
determinations with respect to any distributions of stock, other securities or other property or assets, including cash, in connection
with any corporate event described below; its determinations and calculations will be conclusive absent a determination of a manifest
error.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No adjustments are required to be made for certain
other events, such as offerings of common equity securities by any Underlying Company for cash or in connection with the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">occurrence of a partial tender or exchange offer
for any Underlying Stock by the applicable Underlying Company.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following certain corporate events relating to an
Underlying Stock, where the Underlying Company is not the surviving entity, any payment you receive on the ARNs may be based on the equity
securities of a successor to the Underlying Company or any cash or any other assets distributed to holders of that Underlying Stock in
such corporate event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Following an event that results in an adjustment
to the Price Multiplier for any Underlying Stock or any of the other terms of the ARNs, the calculation agent may (but is not required
to) provide holders of the ARNs with information about that adjustment as it deems appropriate, depending on the nature of the adjustment.&nbsp;&nbsp;Upon
written request by any holder of the ARNs, the calculation agent will provide that holder with information about such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Anti-Dilution Adjustments to Underlying Stocks
that Are Common Equity</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The calculation agent, in its sole discretion and
as it deems reasonable, may adjust the Price Multiplier for any Underlying Stock (and as a result, the Ending Value), and any other terms
of the ARNs (such as the Starting Value), as a result of certain events related to that Underlying Stock, which include, but are not limited
to, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock Splits and Reverse Stock Splits. <FONT STYLE="font-style: normal">If
an Underlying Stock is subject to a stock split or reverse stock split, then once such split has become effective, the Price Multiplier
for that Underlying Stock will be adjusted such that the new Price Multiplier will equal the product of: </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the prior Price Multiplier; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the number of shares that a holder of one share of the Underlying Stock before the effective date of the stock split or reverse stock
split would have owned immediately following the applicable effective date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">For example, a two-for-one stock split would ordinarily
change a Price Multiplier of one into a Price Multiplier of two.&nbsp;&nbsp;In contrast, a one-for-two reverse stock split would ordinarily
change a Price Multiplier of one into a Price Multiplier of one-half.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Stock Dividends.&nbsp;&nbsp;<FONT STYLE="font-style: normal">If
an Underlying Stock is subject to (i) a stock dividend (i.e., an issuance of additional shares of Underlying Stock) that is given ratably
to all holders of the Underlying Stock or (ii) a distribution of additional shares of the Underlying Stock as a result of the triggering
of any provision of the organizational documents of the Underlying Company or otherwise, then, once the dividend has become effective
and that Underlying Stock is trading ex-dividend, the Price Multiplier for that Underlying Stock will be adjusted on the ex-dividend date
(as defined below) such that the new Price Multiplier will equal the prior Price Multiplier </FONT>plus <FONT STYLE="font-style: normal">the
product of: </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the prior Price Multiplier; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the number of additional shares issued in the stock dividend with respect to one share of that Underlying Stock;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>provided</I> that no adjustment will be made for a stock dividend
for which the number of shares of that Underlying Stock paid or distributed is based on a fixed cash equivalent value, unless such distribution
is an Extraordinary Dividend (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-style: normal">For example,
a stock dividend of one new share for each share held would ordinarily change a Price Multiplier of one into a Price Multiplier of two.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Extraordinary Dividends.&nbsp;&nbsp;<FONT STYLE="font-style: normal">There
will be no adjustments to the Price Multiplier of an Underlying Stock to reflect any cash dividends or cash distributions paid with respect
to that Underlying Stock other than Extraordinary Dividends, as described below, and distributions described under the section entitled
&ldquo;&mdash;Reorganization Events&rdquo; below.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An &ldquo;<B>Extraordinary Dividend</B>&rdquo; means,
with respect to a cash dividend or other distribution with respect to an Underlying Stock, a dividend or other distribution that the calculation
agent determines, in its sole discretion, is not declared or otherwise made according to the Underlying Company&rsquo;s then existing
policy or practice of paying such dividends on a quarterly or other regular basis. If an Extraordinary Dividend occurs, the Price Multiplier
will be adjusted on the ex-dividend date so that the new Price Multiplier for that Underlying Stock will equal the product of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the prior Price Multiplier; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>a fraction, the numerator of which is the Closing Market Price per share of the Underlying Stock on the trading day preceding the
ex-dividend date and the denominator of which is the amount by which the Closing Market Price per share of the Underlying Stock on that
preceding trading day exceeds the Extraordinary Dividend Amount.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;<B>Extraordinary Dividend Amount</B>&rdquo;
with respect to an Extraordinary Dividend will equal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>in the case of cash dividends or other distributions that constitute regular dividends, the amount per share of the applicable Underlying
Stock of that Extraordinary Dividend minus the amount per share of the immediately preceding non-Extraordinary Dividend for that share;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>in the case of cash dividends or other distributions that do not constitute regular dividends, the amount per share of the applicable
Underlying Stock of that Extraordinary Dividend.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent an Extraordinary Dividend is not paid
in cash, the value of the non-cash component will be determined by the calculation agent, whose determination will be conclusive.&nbsp;&nbsp;A
distribution on the applicable Underlying Stock described in the section &ldquo;&mdash;Issuance of Transferable Rights or Warrants&rdquo;
or clause (a), (d) or (e) of the section entitled &ldquo;&mdash;Reorganization Events&rdquo; below that also constitutes an Extraordinary
Dividend will only cause an adjustment under those respective sections.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Issuance of Transferable Rights or Warrants.
<FONT STYLE="font-style: normal">If an Underlying Company issues transferable rights or warrants to all holders of record of the Underlying
Stock to subscribe for or purchase the Underlying Stock, including new or existing rights to purchase the Underlying Stock under a shareholder
rights plan or arrangement, then the Price Multiplier will be adjusted on the trading day immediately following the issuance of those
transferable rights or warrants so that the new Price Multiplier will equal the prior Price Multiplier plus the product of:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the prior Price Multiplier; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the number of shares of the Underlying Stock that can be purchased with the cash value of those warrants or rights distributed on
one share of the Underlying Stock.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The number of shares that can be purchased will
be based on the Closing Market Price of the Underlying Stock on the date the new Price Multiplier is determined. The cash value of those
warrants or rights, if the warrants or rights are traded on a registered national securities exchange, will equal the closing price of
that warrant or right. If the warrants or rights are not traded on a registered national securities exchange, the cash value will be determined
by the calculation agent and will equal the average of the bid prices obtained from three dealers at 3:00 p.m., New York time on the date
the new Price Multiplier is determined, <I>provided</I> that if only two of those bid prices are available, then the cash value of those
warrants or rights will equal the average of those bids and if only one of those bids is available, then the cash value of those warrants
or rights will equal that bid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Ex-dividend date</B>&rdquo; means, for
purposes of this section, the first trading day on which transactions in the shares of the Underlying Stock trade on the relevant exchange
without the right to receive the applicable dividend or other distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Reorganization Events</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If after the pricing date and on or prior to the
calculation day, as to any Underlying Stock:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 8%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%; font-size: 10pt">(a)</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">there occurs any reclassification or change of the Underlying Stock, including, without limitation, as a result of the issuance of tracking stock by the Underlying Company;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">(b)</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">the Underlying Company, or any surviving entity or subsequent surviving entity of the Underlying Company (a &ldquo;<B>Successor Entity</B>&rdquo;), has been subject to a merger, combination, or consolidation and is not the surviving entity;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">(c)</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">any statutory exchange of securities of the Underlying Company or any Successor Entity with another corporation occurs, other than under clause (b) above;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">(d)</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">the Underlying Company is liquidated or is subject to a proceeding under any applicable bankruptcy, insolvency, or other similar law;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">the Underlying Company issues to all of its shareholders securities of an issuer other than the Underlying Company, including equity securities of an affiliate of the Underlying Company, other than in a transaction described in clauses (b), (c), or (d) above;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(f)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">a tender or exchange offer or going-private transaction is consummated for all the outstanding shares of the Underlying Company;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(g)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">there occurs any reclassification or change of the Underlying Stock that results in a transfer or an irrevocable commitment to transfer all such outstanding shares of the Underlying Stock to another entity or person;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(h)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">the Underlying Company or any Successor Entity is the surviving entity of a merger, combination, or consolidation, that results in the outstanding Underlying Stock (other than Underlying Stock owned or controlled by the other party to such transaction) immediately prior to such event collectively representing less than</TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 8%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">50% of the outstanding Underlying Stock immediately following such event; or</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">the Underlying Company ceases to file the financial and other information with the SEC in accordance with Section 13(a) of the Exchange Act (an event in clauses (a) through (i), a &ldquo;<B>Reorganization Event</B>&rdquo;),</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">then, on or after the date of the occurrence of a
Reorganization Event, the calculation agent shall, in its sole discretion, make an adjustment to the Price Multiplier or to the method
of determining the Redemption Amount or any other terms of the ARNs as the calculation agent, in its sole discretion, determines appropriate
to account for the economic effect on the ARNs of that Reorganization Event (including adjustments to account for changes in volatility,
expected dividends, stock loan rate, or liquidity relevant to the Underlying Stock or to the ARNs), which may, but need not, be determined
by reference to the adjustment(s) made in respect of such Reorganization Event by an options exchange to options on the relevant Underlying
Stock traded on that options exchange, and determine the effective date of that adjustment.&nbsp;&nbsp;If the calculation agent determines
that no adjustment that it could make will produce a commercially reasonable result, then the calculation agent may cause the maturity
date of the ARNs to be accelerated to the fifth business day following the date of that determination and the Redemption Amount payable
to you will be calculated as though the date of early repayment were the stated maturity date of the ARNs and as though the calculation
day were the fifth trading day prior to the date of acceleration.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Underlying Company ceases to file the financial
and other information with the SEC in accordance with Section 13(a) of the Exchange Act, as contemplated by clause (i) above, and the
calculation agent determines in its sole discretion that sufficiently similar information is not otherwise available to you, then the
calculation agent may cause the maturity date of the ARNs to be accelerated to the fifth business day following the date of that determination
and the Redemption Amount payable to you will be calculated as though the date of early repayment were the stated maturity date of the
ARNs, and as though the calculation day were the fifth trading day prior to the date of acceleration.&nbsp;&nbsp;If the calculation agent
determines that sufficiently similar information is available to you, the Reorganization Event will be deemed to have not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Alternative Anti-Dilution and Reorganization Adjustments</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The calculation agent may elect at its discretion
to not make any of the adjustments to the Price Multiplier for an Underlying Stock or to the other terms of the ARNs, including the method
of determining the Redemption Amount, described in this section, but may instead make adjustments, in its discretion, to the Price Multiplier
for an Underlying Stock or any other terms of the ARNs (such as the Starting Value) that will reflect the adjustments to the extent practicable
made by the Options Clearing Corporation on options contracts on that Underlying Stock or any successor common stock. For example, if
an Underlying Stock is subject to a two-for-one stock split, and the Options Clearing Corporation adjusts the strike prices of the options
contract on that Underlying Stock by dividing the strike price by two, then the calculation agent may also elect to divide the Starting
Value by two. In this case, the Price Multiplier will remain one. This adjustment would have the same economic effect on holders of the
ARNs as if the Price Multiplier had been adjusted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Anti-Dilution Adjustments to Underlying Stocks
That Are ADRs</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of the anti-dilution adjustments set
forth above, if an Underlying Stock is an ADR (an &ldquo;<B>Underlying ADR</B>&rdquo;), the calculation agent will consider the effect
of any of the relevant events on the Underlying ADR, and adjustments will be made as if the Underlying ADR were the Underlying Stock described
above. For example, if the stock represented by the Underlying ADR is subject to a two-for-one stock split, and assuming an initial Price
Multiplier of 1, the Price Multiplier for the Underlying ADR would be adjusted so that it equals two.&nbsp;&nbsp;Unless otherwise specified
in the applicable term sheet, with respect to ARNs linked to an Underlying ADR (or an Underlying Stock issued by a non-U.S. Underlying
Company), the term &ldquo;dividend&rdquo; means the dividends paid to holders of the Underlying ADR (or the Underlying Stock issued by
the non-U.S. Underlying Company), and such dividends may reflect the netting of any applicable foreign withholding or similar taxes that
may be due on dividends paid to a U.S. person.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The calculation agent may determine not to make
an adjustment if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(A)</TD><TD>holders of the Underlying ADR are not eligible to participate in any of the events that would otherwise require anti-dilution adjustments
as set forth above if the ARNs had been linked directly to the common shares of the Underlying Company represented by the Underlying ADR;
or</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(B)</TD><TD>to the extent that the calculation agent determines that the Underlying Company or the depositary for the Underlying ADR has adjusted
the number of common shares of the Underlying Company represented by each share of the Underlying ADR, so that the market price of the
Underlying ADR would not be affected by the corporate event.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Underlying Company or the depositary for
the Underlying ADR, in the absence of any of the events described above, elects to adjust the number of common shares of the Underlying
Company represented by each share of the Underlying ADR, then the calculation agent may make the appropriate anti-dilution adjustments
to reflect such change. The depositary for the Underlying ADR may also make adjustments in respect of the ADRs for share distributions,
rights distributions, cash distributions and distributions other than shares, rights, and cash. Upon any such adjustment by the depositary,
the calculation agent may adjust the Price Multiplier or other terms of the ARNs as the calculation agent determines commercially reasonable
to account for that event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delisting of ADRs or Termination of ADR Facility</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If an Underlying ADR is no longer listed or admitted
to trading on a U.S. securities exchange registered under the Exchange Act or if the ADR facility between the Underlying Company and the
ADR depositary is terminated for any reason, then, on and after the date that the Underlying ADR is no longer so listed or admitted to
trading or the date of such termination, as applicable (the <B>&ldquo;termination date&rdquo;</B>), the applicable Underlying Stock will
be deemed to be the Underlying Company&rsquo;s common shares rather than the Underlying ADR. The calculation agent will determine the
price of the Underlying Stock by reference to those common shares. Under such circumstances, the calculation agent may modify any terms
of the ARNs as it deems necessary, in its sole discretion, to ensure an equitable result. On and after the termination date, for all purposes,
the Closing Market Price of the Underlying Company&rsquo;s common shares on their primary exchange will be converted to U.S. dollars using
such exchange rate as the calculation agent, in its sole discretion, determines to be commercially reasonable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Basket Market Measures</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the Market Measure to which your ARNs are linked
is a Basket, the Basket Stocks will be set forth in the applicable term sheet.&nbsp;&nbsp;We will assign each Basket Stock a weighting
(the &ldquo;<B>Initial Component Weight</B>&rdquo;) so that each Basket Stock represents a percentage of the Starting Value of the Basket
on the pricing date.&nbsp;&nbsp;We may assign the Basket Stocks equal or unequal Initial Component Weights.&nbsp;&nbsp;The Initial Component
Weight for each Basket Stock will be stated in the applicable term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Determination of the Component Ratio for Each Basket
Stock</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;<B>Starting Value</B>&rdquo; of the Basket
will be equal to 100.&nbsp;&nbsp;We will set a fixed factor (the &ldquo;<B>Component Ratio</B>&rdquo;) for each Basket Stock on the pricing
date, based upon the weighting of that Basket Stock.&nbsp;&nbsp;The Component Ratio for each Basket Stock will equal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the Initial Component Weight (expressed as a percentage) for that Basket Stock, <I>multiplied by</I> 100; <I>divided by</I></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>the Closing Market Price of that Basket Stock on the pricing date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each Component Ratio will be rounded to eight decimal
places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Component Ratios will be calculated in this
way so that the Starting Value of the Basket will equal 100 on the pricing date.&nbsp;&nbsp;The Component Ratios will not be revised subsequent
to their determination on the pricing date, except that the calculation agent may in its good faith judgment adjust the Component Ratio
of any Basket Stock in the event that Basket Stock is materially changed or modified in a manner that does not, in the opinion of the
calculation agent, fairly represent the value of that Basket Stock had those material changes or modifications not been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table is for illustration purposes
only, and does not reflect the actual composition, Initial Component Weights or Component Ratios, which will be set forth in the applicable
term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Example: The <B>hypothetical</B> Basket Stocks are
Stock ABC, Stock XYZ and Stock RST, with their Initial Component Weights being 50.00%, 25.00% and 25.00%, respectively, on a <B>hypothetical</B>
pricing date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 49%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in; border-bottom: Black 0.5pt solid"><B>Basket Stock</B></P></TD>
    <TD STYLE="width: 11%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; border-bottom: Black 0.5pt solid"><B>Initial
Component<BR>
Weight</B></P></TD>
    <TD STYLE="width: 13%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; border-bottom: Black 0.5pt solid"><B>Hypothetical
Closing Market<BR>
Price<SUP>(1)</SUP></B></P></TD>
    <TD STYLE="width: 14%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; border-bottom: Black 0.5pt solid"><B>Hypothetical<BR>
Component Ratio<SUP>(2)</SUP></B></P></TD>
    <TD STYLE="width: 13%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; border-bottom: Black 0.5pt solid"><B>Initial&nbsp;Basket<BR>
Value<BR>
Contribution</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Stock ABC&#9;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">50.00%</TD>
    <TD STYLE="text-align: center; text-indent: 0in">50.00</TD>
    <TD STYLE="text-align: center">1.00000000</TD>
    <TD STYLE="text-align: right; text-indent: 0in">50.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Stock XYZ&#9;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">25.00%</TD>
    <TD STYLE="text-align: center; text-indent: 0in">24.00</TD>
    <TD STYLE="text-align: center">1.04166667</TD>
    <TD STYLE="text-align: right; text-indent: 0in">&nbsp;25.00</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-indent: 0in">Stock RST&#9;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">25.00%</TD>
    <TD STYLE="text-align: center; text-indent: 0in">10.00</TD>
    <TD STYLE="text-align: center">2.50000000</TD>
    <TD STYLE="text-indent: 0in; text-align: right"><U>25.00</U></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="4" STYLE="padding-left: 74.9pt; text-indent: 0in">Starting Value of the Basket&#9;</TD>
    <TD STYLE="text-align: right; text-indent: 0in">100.00</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt">(1)</TD><TD>This column sets forth the <B>hypothetical </B>Closing Market Price of each Basket Stock on the <B>hypothetical </B>pricing date.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-weight: normal">(2)</FONT></TD><TD><FONT STYLE="font-weight: normal">The </FONT>hypothetical <FONT STYLE="font-weight: normal">Component Ratio for each Basket Stock
equals its Initial Component Weight (expressed as a percentage) <I>multiplied by&nbsp;</I>100, and then <I>divided by</I> the hypothetical
Closing Market Price of that Basket Stock on the </FONT>hypothetical <FONT STYLE="font-weight: normal">pricing date, with the result rounded
to eight decimal places.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Ending Value of the Basket</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The &ldquo;<B>Ending Value</B>&rdquo; of the Basket
will be the value of the Basket on the calculation day. The value of the Basket on the calculation day will equal the sum of the products
of the Closing Market Price of each Basket Stock on the calculation day <I>multiplied by</I> (a) its Price Multiplier on that day, and
(b) the Component Ratio for each Basket Stock.&nbsp;&nbsp;The value of the Basket will vary based on the increase or decrease in the price
of each Basket Stock.&nbsp;&nbsp;Any increase in the price of a Basket Stock (assuming no change in the price of the other Basket Stock
or Basket Stocks) will result in an increase in the value of the Basket.&nbsp;&nbsp;Conversely, any decrease in the price of a Basket
Stock (assuming no change in the price of the other Basket Stock or Basket Stocks) will result in a decrease in the value of the Basket.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specified in the applicable term
sheet, if, for any Basket Stock (an &ldquo;<B>Affected Basket Stock</B>&rdquo;), (i) a Market Disruption Event occurs on the scheduled
calculation day or (ii) the scheduled calculation day is determined by the calculation agent not to be a trading day by reason of an extraordinary
event, occurrence, declaration or otherwise (any such day in either (i) or (ii) being a &ldquo;<B>non-calculation day</B>&rdquo;), the
calculation agent will determine the Closing Market Prices of the Basket Stocks for that non-calculation day, and as a result, the Ending
Value, as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The Closing Market Price of each Basket Stock that is not an Affected Basket Stock will be its Closing Market Price on that non-calculation
day.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 27.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>The Closing Market Price of each Basket Stock that is an Affected Basket Stock for the applicable non-calculation day will be determined
in the same manner as described in the second-to-last paragraph of subsection &ldquo;&mdash;The Starting Value and the Ending Value&mdash;Ending
Value,&rdquo; <I>provided</I> that references to &ldquo;Underlying Stock&rdquo; will be references to &ldquo;Basket Stock.&rdquo;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of determining whether a Market Disruption
Event has occurred as to any Basket Stock, &ldquo;Market Disruption Event&rdquo; will have the meaning stated above in &ldquo;&mdash;Market
Disruption Events.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Role of the Calculation Agent</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The calculation agent has the sole discretion to
make all determinations regarding the ARNs as described in this product supplement, including determinations regarding the Starting Value,
the Ending Value, the Price Multiplier, the Market Measure, the Closing Market Price, the Redemption Amount, any Market Disruption Events,
any anti-dilution adjustments, any successor Underlying Stock, business days, trading days and the calculation day.&nbsp;&nbsp;Absent
manifest error, all determinations of the calculation agent will be conclusive for all purposes and final and binding on you and us, without
any liability on the part of the calculation agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We or one of our affiliates may act as the calculation
agent, or we may appoint BofAS or one of its affiliates as the calculation agent for each issue of the ARNs. Alternatively, we (or one
of our affiliates) and BofAS (or one of its affiliates) may act as joint calculation agents for the ARNs. When we refer to a &ldquo;calculation
agent&rdquo; in this product supplement or in any term sheet, we are referring to the applicable calculation agent or joint calculation
agents, as the case may</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">be. However, we may change the calculation agent
at any time without notifying you. The identity of the calculation agent will be set forth in the applicable term sheet.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Same-Day Settlement and Payment</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The ARNs will be delivered in book-entry form only
through The Depository Trust Company against payment by purchasers of the ARNs in immediately available funds.&nbsp;&nbsp;We will pay
the Redemption Amount in immediately available funds so long as the ARNs are maintained in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Events of Default and Acceleration</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Events of default are defined in the senior debt
securities indenture.&nbsp;&nbsp;Notwithstanding anything to the contrary in the accompanying prospectus supplement, if such an event
occurs and is continuing, unless otherwise stated in the applicable term sheet, the amount payable to a holder of the ARNs upon any acceleration
permitted under the senior debt securities indenture will be equal to the Redemption Amount described under the caption &ldquo;&mdash;Payment
at Maturity,&rdquo; <I>provided </I>that such Redemption Amount will be determined as if the date of acceleration were the maturity date
of the ARNs and as if the calculation day were the fifth trading day prior to the date of acceleration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If a voluntary or involuntary liquidation, bankruptcy,
insolvency or any analogous proceeding is filed with respect to the issuer of the ARNs, then depending on the applicable bankruptcy law,
your claim may be limited to an amount that could be less than the amount payable upon default and acceleration as described above.&nbsp;&nbsp;In
case of a default in payment under the ARNs, whether at their maturity or upon acceleration, and whether in an insolvency proceeding or
otherwise, the ARNs will not accrue any default or other interest rate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition, as described elsewhere in this document
as well as in the accompanying prospectus supplement and prospectus and in the applicable term sheet, under the U.K. Banking Act 2009,
as amended, the relevant U.K. resolution authority may exercise a U.K. Bail-in Power in circumstances in which the U.K. resolution authority
is satisfied that the resolution conditions are met. Accordingly, and notwithstanding anything to the contrary above, any payment on the
ARNs (including, without limitation, any payment following an acceleration permitted under the senior debt securities indenture) will
be subject to the exercise of any U.K. Bail-in Power by the relevant U.K. resolution authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Listing</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless otherwise specified in the applicable term
sheet, the ARNs will not be listed on a securities exchange or quotation system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="font: 9pt Times New Roman, Times, Serif; margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><A NAME="a_005"></A>SUPPLEMENTAL PLAN
OF DISTRIBUTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BofAS and one or more of its affiliates may act
as our agents for any offering of the ARNs.&nbsp;&nbsp;The agents may act on either a principal basis or an agency basis, as set forth
in the applicable term sheet.&nbsp;&nbsp;Each agent will be a party to the distribution agreement described in the &ldquo;Plan of Distribution
(Conflicts of Interest)&rdquo; on page 77 of the accompanying prospectus and on page S-103 of the accompanying prospectus supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each agent will receive an underwriting discount
that is a percentage of the aggregate principal amount of the ARNs sold through its efforts, which will be set forth in the applicable
term sheet.&nbsp;&nbsp;You must have an account with the applicable agent in order to purchase the ARNs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">None of the agents is acting as your fiduciary or
advisor solely as a result of the making of any offering of the ARNs, and you should not rely upon this product supplement, the applicable
term sheet, or the accompanying prospectus supplement or prospectus as investment advice or a recommendation to purchase any ARNs.&nbsp;&nbsp;You
should make your own investment decision regarding the ARNs after consulting with your legal, tax, and other advisors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BofAS and its affiliates may use this product supplement,
the prospectus supplement, and the prospectus, together with the applicable term sheet, in market-making transactions for any ARNs after
their initial sale solely for the purpose of providing investors with the description of the terms of the ARNs that were made available
to investors in connection with the initial distribution of the ARNs.&nbsp;&nbsp;Secondary market investors should not, and will not be
authorized to, rely on these documents for information regarding Barclays Bank PLC or for any purpose other than that described in the
immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 31; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
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MNESRS]HCX]OX+\WPAX6D_P")[/$WVR[4,!I\)7=(8Y .)]G$8!#%F !S7T'
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MEY+5Z=CK716M=^2WZ(^1?VM?&4&C>";;P_$P_M#7+Q BY*^7#$CL[Y7IRZJ
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H]=-3W,*$ 4;5 Z+CH/S&/I^'-?)7]?R_0_0TDDE%64=$EHEY)6/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP!#  (" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @+_Q &B   !!0$! 0$!
M 0           0(#! 4&!P@)"@L!  ,! 0$! 0$! 0$        ! @,$!08'
M" D*"Q   @$# P($ P4%! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$(
M(T*QP152T? D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBI
MJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W
M^/GZ$0 " 0($! ,$!P4$!  ! G<  0(#$00%(3$&$D%1!V%Q$R(R@0@40I&A
ML<$)(S-2\!5B<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%56
M5UA96F-D969G:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X
M^?K_P  1" "S IL# 1$  A$  Q$ _]H # ,!  (1 Q$ /P#]K/'WQA\$?#35
M?#VA>)3XPNM;\4:?X@U;0]&\%?#/XE_$S5;G2O"MSX=L_$&IW&G_  V\(^++
MO3-/TV[\6>'+66]U2&RMI+G5[2"WDEE9U0 X_P#X:6^'7_0N?M ?^(G?M3__
M #FZ #_AI;X=?]"Y^T!_XB=^U/\ _.;H /\ AI;X=?\ 0N?M ?\ B)W[4_\
M\YN@ _X:6^'7_0N?M ?^(G?M3_\ SFZ #_AI;X=?]"Y^T!_XB=^U/_\ .;H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * /G_ ,1_\G3_  ;_ .R ?M+?
M^K%_9.H ^@* "@ H * "@ H * "@ H * "@ H * "@ H * /G_XR?\E%_9._
M[. \1_\ K+/[2U 'T!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MYRPSK8NIB:N#A&K7A++IX.I[>K4E4D?!/Q7N?BYXI^#G[>A\<>/-*UWP_P"
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MP_"^7\31IX6+I54\?G&;\/T\N=:HZL9?\*>5*K+'_5Z:IX+%\SP4ZN&E&O\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?/_ (C_ .3I_@W_ -D _:6_]6+^R=0!] 4 >>:Q\*/A[KOQ"\*?%75O
M#5M=^/\ P1IVJ:5X8\1&[U&&;3;#68I8;Z![*WO(M+U ^5<W:6<VIV-Y<:8+
MZ_.F2V9O[PSO#MX.ICJN&_<U,RPM'!8Z4?\ E_AL/7^LT8.,KQA*%7>K34*T
MZ?[F=25%NF%;]]1PV'JN4J.$Q-3%X>FI2A&%>K"C"HY<CBZM.?U?#5'0JN=#
MV^&PV)5-8C#T:L.8\7?L\?![QWJWB/6/%OA ZW)XOTZWTWQ7I-SXA\4Q>%/$
M:V=LMG8:EK?@FVUN#P=J7B/3;2."VTKQ7=Z%+XGTJ"VM(M.U>V2SM1%G"E"E
M3G2AS4XRQ7UZFXSG&I@\;>DWC,NK*2JY9BIRHTIU,1ET\+6JS@IU)RG>3Z/K
M5=3P\U.T\+1>&IR481E/"2G7J/!8EJ*>-P/M,5B9K XSV^$C+$5W&BG6J<V?
MX7_9H^$7A#7-5\1:;I_C;4M4USPL?!&M-XS^+_Q@^(=CJOA+%V(M U'2/'WC
MSQ+I%YIMI_:&H'3X)[&3^SCJ%^; VQO;HRW5M7PN.P5:,*N&S.?M,=3J0A)U
MZRC"'UAU)1=6&)]G"%)XFG.&(=**I.I[/W3"DY4*F7U:$ZE">4SE/+O8U)TH
MX-S4>:-&G3E&G&E)TZ525%Q=)U:&'K.'M</1G3R]"_9-^!?AOQ'X6\7Z5X=\
M4KXG\$[8?"FN:C\5_BYK6HZ'I:V_V0>&;.?6O'6H,/!36^8G\#2>9X/E4GS-
M#8DDZ0JU*=7$5K\];&8?$87'U*\8XB>8T<3[/VBS.6(51YE4C*E3JX>OCOK%
M?"5X_6,+4HUVZCPK8>C6ITJ$J<:='#8BEBL'1P]\)2P%>BZKC/+J>%=&&7*I
M&M4HXBG@8X>GBL,XX7%0K8:$*4>T\,_ [X:^#O$47B?P]H^K65]:?:SI&FS^
M,_&^I^$O#1OX9+>^/@_P'JOB.]\$>#&O()IHKEO"GA[1S/'/.LA83RAYHREA
MJ4Z5*349T*>%E.HW6KK"4JD*M+"1Q-;VF(AA(3I4''"PJQH)8?#1]GRX:@J>
ME>,:]?ZQ57[SV]3%24&Z5*IBZL91J8NK0I.%"MBYJI5OBJM.=?FKXB2J<V(K
MNIY+\7_A!X_\2?$H^./#/AOX?>++&X\!0>#8K?5OB;\0_@5XO\-W4>LWVJW.
MKV/Q ^&/@WQAXAUN.Y6XM(]+L97\/S>$[BVU"]T+4%G\0ZJ6QP\/9/'4Y7HK
M'8K!5WC,/5J1J4:."P\Z,*,L#!8>.)G*>(Q52M6GCZ7UG#NCEU6FL/!U'U5:
ME.I0P$+R_P!BGCG+#U*-*K3K/'_5>:M2Q%64I8*5&."HQ5&EA:D:U:4<95K>
MVP>"A2Z#X:?LZZ;X9U'P;X\\>>(_%OC?XO>$=&UOPY:>+Y_B%\2AIT7AC5]5
MN[VW\,S^';GQ:^@^(K33[%]*L+K6?$^CZAK?B6_T'3/$VNW$^O6]M=6W?]8C
M1EB7A8J#S#!97A\UG.C14<PQ>7X2E1GCHX11EA<M=7%?6\7A\-ET*%' /'XV
MGA>58O%RQ'G1I5)PC'$M>SP^.QF*RZC"I5E_9U+%8AU8X:.+FUBL6XT_9X>M
MB<3)U,50IT\-4BL)1H8>EVTWP(^%\WBA_%KZ#J2W\FIMKD^CQ>,/&L'@6YU]
MY6GD\17?PT@\11_#J\\1RW#&XF\0W/A:769KC;/+?/,JN.&E2IT:4Z$81=&=
M#%X6-*JE7A0PV/A4I8VAA(UO:+!4L33K5Z=:G@_81G#$XF+7+B:ZJ=59RK5(
M5JDIJK"6%FZE*<J$ZLL#R?4WB94'3>+^K>RHN@L4ZRIO#X9Q2>&H.GS6G?LM
M?!#2+GPQ?:=X7UJTU'P1JG]J>#-53XA_$HZOX1C:(V\GAWPSJS^+VU+0? <]
MM_HMU\.-+NK7P!=V@6UNO#4MNBQCIIXBO3K1Q$:DG76'EA:]:J_;5<?0G*,_
M9YO.MSRSGV=2$*M&6;/&3P]6$*M"5.I",EG5ITZM.O1G3A[*M6EB%2C"-.EA
M<3.4Y3Q.74Z:C#*L3-U*BGB,LCA*TX3G3E-PDXO;@_9\^%%KI?B;1(-!UB/1
M_%6N3>)[[2O^$Y\?'3]'\27&I7FM3:_X'M'\3M!\-M9DUB_O-6;4_AXGA>\.
MISO?^=]JVRC",>2A@L/&52,<M2C@*JJU5B\)26%^HQPU#'\_UV&#A@G+!T\$
ML1]4IX2=3#0HQHU)PEHVGB<3BY0I2J8OD>+IU*-*>#Q4X5:>(C6Q.7SA+ U\
M3]8HT<1+%5<-/$5*]*E6G5E5IPE'&E_9?^#LTOA6XGTWQQ->^#/$\WC30]2F
M^,?QEDU=O%<]K#I[:_KNL/X^;5/%FI)I<(T:VN/%=WK36FA2W>AVHATB]O+*
M?>E7J4,11Q5'V=.KA\-/!THQHT50CAZTG/$4WA.3ZK-XR;Y\?4J495,?.,)8
MR=>5.FXQ4C[7#8C"5)594<3[+VR=6JJC6'J.MAH0KJ:KT:>$KMXC!TZ52%/"
M8EO$8:-*N_:'T#6)04 % !0!\_\ QD_Y*+^R=_V<!XC_ /66?VEJ /H"@ H
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MPT5K:QN[KST@@E9.O%1P]">-=#$JOA<OIT*N*Q;IRP]/#4L13PDX5,5&H_\
M9:<WCL+&G.M*$:RQ.&G!N.)H\V24OK%/"\K57$YCC,NRZE_R^S"IA\9C,+2C
MAJ/\2>)KK!U9SP4%/$8>K3KX:K'VN&K<O06_QN^"]U:>%[^T^+OPON;#QO>S
MZ;X+O;?Q]X4FM/%VHVUT]C<Z?X7N8M6:'7[VWO8Y+2>UTE[N>*Z1[>2-959
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MT5>MA8\W+?$TEK5H+][!:RBA/B[\8?AY\"O ^J_$+XF>(['PYX=TN*78US/
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MTXU,1&]&$DXRFFK'.77Q]^!-C%K$]Y\:OA+9P>'K^TTK7YKKXC^#K>+0]4U
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M5(X>CC>*,1Q'%X-U;4%5Q^-FHXRKB8/%4\7+*<;7P-;#X".*P56%9X".)P^
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M_$.K-X;V<<)@\+')J-6-&GBE/^R:./YG'!0BWCW]9J1=>4I:5Y\,/BW^T9X
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M2UTS0] TVTTC2K"WC4*L5K86,,%M @ &1'&NX\L2230&WE;Y6N;M !0 4 %
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MM+-L$Z,<)F6,M-U?K+PV'>$Q6+\=O/VM/VC_ !=\//A_\1/!G[//ASP1X/\
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M+3M'UG4K^#QKX9\/6\>GKX?L?#?P_P!:U*Y72SI/K3K4<5G$\VS-6R;-\/\
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M645"$\/6I2ITZ<'&G'TZN,L* "@ H * "@ H * "@ H * "@ H * "@ H *
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M 4 % &9K&K6.@Z;=:KJ,CQVEHBEA%%)/<32RR)!;6MI;0J\]U>WES+#:6=I
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M(2Y:DXM,]#K(#Y_\1_\ )T_P;_[(!^TM_P"K%_9.H ^@* "@ H * "@ H *
M"@ H * "@ H * "@ H * /G_ .,G_)1?V3O^S@/$?_K+/[2U 'T!0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 >1_#3_D9_CA_V52V_P#56_#2MH?\BG)O3/\
M_P!:[B$5;_?J_P#V!Y7_ .H<3URL1A0 4 % !0 4 % !0 4 % !0 4 % !0
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MX4EA(S:U<7+-<=*BGRJ$OK#CS.I/EK_!W_D!^+/^RK?%?_U/M=HI?\B_*?\
ML _]W,8:8S_D:9C_ (,A_P#63X?/6:#(^?\ Q'_R=/\ !O\ [(!^TM_ZL7]D
MZ@#Z H * "@ H * "@ H * "@ H * "@ H * "@ H ^?_C)_R47]D[_LX#Q'
M_P"LL_M+4 >%?&/Q]\5?#_QG\9Z!X'\;_%[4=2LO /P[\3_#SX6^&/A1X>\5
M_#W6O$VN:SXUT;4M&\>^.+;X2:KJ7@KP[J2^&M-N/[5\0_%+P>;.6YUF]L=3
MGLK-=.L[RV*;YZD:V+Y.)Z>#Q=.LJ>%P]'(G@<DQ6-E@\7.>786>986AC,RK
MX6C4QM>M*M3P%*OA,1#$4Z6*VS.G"GE^!JTY_4IU\OSM*MAH2QF)J9E@:E&6
M6N> ;Q%65#$5L72P>,E2I8;#_5H*2Q6 K1KXY>A^&?VG=/\ 'L6E7&E_#?XV
M^&[./XEK\.=0U"^TGX966G-XQTZ7Q#9ZOX9FGU+QGJ3:QH]IJNA_V1J7B'P5
M'?V7]HW^G1:9XA,=MXAETA<D8PRW%4Y\]/,LOS+,LMPS3IU<PP^&R&IFL%.E
M.-.KA*E2C];JY>\15P5"OC<HJ.O6GE>(PD\TY*DIT7CL-7C[*ME^+RW!YA6H
MM5:6"J8S/,'EL*E.HN:%>C6=?"RQ%.%&MC:&5YG";PF%S2+IX.MX8_;*\!^(
M[:YO)? 'Q<\,VRZ?J-QI,GB/PUH%O_PDVKZ-XM\.^!-8\,>&TTOQ;JSZEJUA
MXP\6:#H/]I%8/"&I7=Z\NB^)]3LK'4+JUJG2G6PE/%82+Q*Q/]C3P6'I?NL3
MC,-G]#&XC+<93IXGZNL+AJU++\94G+,IX&I2H4EC*E.."K8?$U=U&2JXBE*+
MIQP57-\/F%>W/0P&(R3#8K&X^A5G0]J\14A@L'B,3'^SXXR/[N6%G*&/C/"1
ML>(_VG++PDFM^(?%?PS^.?A:W\(?#KQ3XUU[PKJ6E?"I8WTKPUXB\/Z=XCU"
M">'QQ>3:QJ?AC3]4L]9AG\-^)+GPIK&@ZIJ%MI,_B3Q=8#1M+E.E"C7K.I3E
M1^N<.8251PQ"J8.6=8C/,%0J+#0I1Q7LZF.RZOA<;&MAZ^(DL-EV-RBC5RS&
MSQV,S@JE:OAL-3IU8XF=//ZE+#VIQ6,EE67Y3F,:2KS;PSGB:&84HY=*CB:-
M&CBY8_!Y]6P.(PBHT*>M_MG?#WPYX(G\<:UX,^(VBVUK<VQGT;Q%#X \'ZI;
MZ+J6EV^M:+XCN[_QE\0?#WA.PLO$&F7=K-HNAW_B:U\;WUY-_8J^%$UZ*XTN
M%5TL+B*>%K-4ZWM\5A,9"%Z\LNQV"^I/%X"K3PRK5<?C:-/,<'7^KY'3S:=:
MA5G6H*K3P^*E1K#6Q492PWOPE2PF(PE3X*>-PF.J9C1PV-I5)\L,)@IU<IS"
M$L7FLLNP\)4:?/4BL9@7BO3O 'BO5]=^*/Q%LSX@U'5/",G@KX2^,O"NDW]A
MH=JOAX>+8/&,.HVUE/INDV&JW%M?IH&GZA+'K^H:W=6M]->1V=W;V+PV5OU?
M5987!XVGB$GC,#Q7G.4SK*6^'PN4<-8VG0M#DHN.'Q.98R-*K&E&M.E*"KU*
MLH*1PPQD<5BLMJ89.E@\9POE^91I.-G*OB,USFE]9FY2J3A5JX6AA:52E"HL
M/'V*E3I0J3K3J^O:UJMIH.CZKK=\_EV.CZ;?:I>/D+LM;"VENYVRQ"C$43'D
M@>I%>9BZT\-A:]:E2G7JTJ4Y4</2C*=7$5N5^QP]*G!.<ZM>JX4J5.$7.=2<
M8Q3DTGZN&H/$8BAAHRC3=>M2HJ4G:$'5G&'-)](QYN:3Z)-GQ)\//VJKGP]\
M)_&OC+XLZ3\1M9U'P1XW\/V?B"VC^&U_X-\4:1X>^)3:1=^'KJ+P+XMTOX?^
M(M3\/>&-6UN\\$6U]I6B:OK_ (D3PT^J:?;>(KJ>XG;T*].E1I9+2I36*JXK
M%XW()XG#Q;6)SG U:WU)U\+&I5K8'%Y[@*N38I8:5&C0P>)S:G]8C@<NC+$T
MN:@_K6,S9TG2PU"GED>)<'@Z]3V=7"9)["O]9HUL3-?4ZU; U,JS?$U<12QN
M)PE7#T>2AC*N+<<%'K]"_;,\#:M/J]OJ'PY^,OA(Z%;^(8]4D\3>$M%@A@\2
M^&VMFO? ]J^D>*M8_M7Q5+:7VGWD4>C#4-#MQ?P:=JFN:=K<=WI5MA%*<(.A
M.G7J5Y4*> H4IQC/,*M7.<)P[7AA9UG2H*&#SW'X7+*^+Q5;#8&K5J3Q& Q6
M-P.'Q.*HJK4IX>5JLW3I0YJF(KNG65/"85Y'C.),/C,1!4OK$(8O)<!C,;1P
ML*$\SIQH*GC,!A:V(PM.OU^F?M):9>:Z?"E_\,?B=X;\4PZ;XPO;[0-=/PTB
MN=-O?"&AZ1XE;1+J_P!.^)6I:%)>^(="US3=1T#4[#5KSPMB6>SUSQ%H>HV5
M]9V^->M1H8?'8F-6%:EE^65,TK*BVI.GA<?0R_,,-%5E15/%Y=5Q6#K5Z>(=
M"EB,)C,-B<NK8ZE4NNBG1J.OEM"<70_M/'X3 T)U+N$%F&&S+$X/&584/;5O
MJM>639OAN2E1JXVEBLOK4\1@Z4*F%J8CBM2_;1\#Z=IWA'5H_AK\8M3T[QE\
M*['XS:?>:/H7@Z^M=.\!R0?:M=U+7KE/':6^D3^$[=[635[:XEW:K)?6MIX*
M;Q9?>?:P>G++ZT,YQF1N5..)P&897E^)K2]I3PD)9W6>$RO$1J3IQG*EB\=&
MM@XT(TGF,)X?$8JM@:>7T9XU8^]:@H0]I6Q-;-\+A<-1G2JU:^-R2NJ..PM-
MTZDJ-U3G3Q-/&2K1RR=&K1IO'1QE:EA9^P_#[XG:SXT\>_%KPE=^!M:T#2?A
MUKVC:-I?B:\N_#$VG>(AJ?A;0O$3>3!IOBC4M;M[GRM:BNXDOM!TVV73)K-9
M;HZM]OTZQY*-.3P$<757L*DL?C\+'#2LYNE@J\\*ZL94G5I->UHSE4<ZM*=J
M]"%.C-4ZU4=:U.M@(T5*>'QV1X/-H5[*,8RQ.+QU!P<92A5C%K#.A!>Q<OK.
M"Q\YS6&JY=4Q/LE0]/EV5]O):_) >%>$?CGH?BSXF>)?AY:Z-\0+632+?3S8
MWFK_  7^,GA?2VN=NM'5S?>+/$O@O3/"<5F_]G0?V!=MJ-K;:[OF_L6YU?*^
M6\&OK6"KXJ-H>RQE:,8U6L++ZFL!D5>BG1Q'LZW]H?6<SQ/M\"HK&4<)"AB*
MV#I4.;$5<\3/ZIC:>%DKQGA</*]&,L1;%SQN=4JK=3#>TIPP'U?+\/[''2M@
MZN)G7H4\75JVH4M'X9PR#Q-\>5^UW&9_BM"8FVV@:R#?"GX9(%M@+8*RHP,R
M_;%NF,CL'9X0D2G)+^P\JA&K.$I0XCY:T52]I3<^+N(W%P4J<J+=&Z]G[2E-
M/E7M55][FUJ-1S*K)PBXQPF3WHMS5.7+@X\W,XRC57M?M\M2-K_N_9GQCX-_
M:%\?> ;&7QIXJUSX_?&7P;X>E\?6OQ7DUKX/>$/"ND>#;/0/&4_ASPSKWP_\
M1V7P[^#>E?$&2=8C_P )%H_A;6OB-?7%O'<W6CV%G>VT&F:FL/6IO"Y94K4.
M6EFF3<+U:&*Y:RQG^LF?X?*)QRZGERF\56RK$U<;C88;%T<NK>RJK*^;'5\+
MBZE>&%15>?,/9SI1K9;GW$U*>&IU8/"OAW)*F?QEBIXQQJ86CF>&C@,K=:CB
MLSP5U5S.$L*L1AU1H>Y>(OVK-&\&27FO>)?AQ\>;"Q&B?"^Y;PRWASX<7MSI
M]M\2O$7BC0/#FL0:!I'BVZ\<S:QJ&N:;;Z!K>@2&^U"Q>;0'L/#,!/B2^AWC
M0J\ZPD:<:F+K9G5RZG3IU(59PQM'(J6<?4XUZ%1X#V%6G]9HK&SK3PM+&83%
MU,1CL/E7U7%UNA6E@*.814:.#5+,\2J]15*$L1A<%F64X#$5ZM'$<M2E#!X?
M,,+F]"G['#8FME^/K4I4<5F]*EE>&ZR#]I;2;O2]'GT[X6?%[4O$NH/XQ;4?
MA]I^C>#[GQEX8L? .KV>B>+-2UE$\<#PW=1Z;J&HZ?%;Z9X8\1^(O$6MM>Q1
M>']%U6XCN88(4$W"5*I"KA/8X.MB,?252>&P:QV)S#!X>%:G&G]=JS>+RK,J
M,E@<)BXQ6#K8CF^J<F(G$+VE&<5A<2ZL:6%P6)J4:&(QDJF P6:0E1<JOU?#
M4GE^98'$U*N95\#3PSQ-+"XN6'QTEA3F=2_:IT3PI<Z-IMY\//C=XAUCQKX^
M\;^"_#&B6VC?#2;5#XE\*I%?2>&H(++QEI,5A87>@K=^(](U7Q',D=EI%G?Q
M^,M<T75X[?2WQH.,XT*<97:RK,,XK5W[\:6!R[.\9EF<5,55P\985/(L3"GA
M)_55*&8T'@5D\\[S#$595E*2C]:K2YJ5&AC\LR^494YP5*MFF28#,,K=.E*'
MUQ4\WA7C.U>+K8+'UL3''TLKR^E2]CK:=^UA\-?$/CSP-\-]*@\46U_\3=)@
MO/"7B*;_ (0W3;>62_\ "$OC2-;;PYK7B>/Q]>K9:*JM>>(+'P!J_@BPUEDT
M'4=?75EGTY-Y8+$5IYQA*514:^683%XBI5I2I59>QH5Z6$^M4HQAB50C.M74
M\&\TH86&-A2J3P\,1!)3VK1G@*>&Q&)H+7%?5\3A*LXTYX6O3S">65<+B7&M
M1A7K0QU.6&Q.'RG$XS%X>G.&,JPHX*I#%OT[X(:SKFO_  L\(ZIXDUBY\0:Y
M-:7T&H:W>VNDV-YJDMCJ^H:>M[=VFA:=I&C07,\-K&\Z:9I>GV?FES!:0(0@
MGGC5P^68F-*G0>,R3(<PJTJ3J^RAB,QR7 8[$JG[:I6JQIO$8BJX1G5FXQ:C
MS-)'-!2IULRH2J3J+!YYQ!@*4YJFIO#Y?GF88+#*?LH4X.<</AZ4924(N;3G
M*\I-OE?VD_'/B7P/\-IG\$W6M:?XQU_4[;0_#VI>'O NN?$G4]*G\BZU6\U&
M/P7X<\/^*=6U>&+3],N;:4Q:%>V]D]W%>7WV>TAEN(N*MB)8?$81QHSQ%.@Z
M^8XO#0YH1Q&#RZC*N\'6Q*A*& P^98UX#**V85)4(X6.8^TI5Z>)^K\W?AZ5
M&4:KKSC2I_[/AU+VU.C6C+&XJAA*M?!QJ1G'$XW+<%5QF=4,%[&NL4LLJ4ZM
M"IA_;V\Y\3_MG^!O!FB^!=6U/P-\4-:@\<?"JY^+-C=>%-!T'4K2T\/:#!87
M'CE=66^\3Z1?:'=>![74+>]UL:U8:;;78FBTCP]<:WXF==!KU,30A1S',\'2
MJ*=#+L3ET7C(7K86IE^<UJ]#*\SP]3#>W>)P^*K4Z=&E0PRK9CB)8BE7PF"Q
M.#C7Q5'AP%+'5\%E4I8:I+,,=6Q.5RR]<E#%T\^P/L88G*JM/$2P]*CB)U'B
MY1JRJ1P.'AE^,>/Q6"?U:.)TM*_:]\*ZY%.FB?"[XT7^L6;:I?ZCX8D\->&-
M&\1:9X/TK2?#&O3>/+ZQ\0^--'AAT*XTCQEX;O;+0UNG^(5S_:7V1?!(O[/4
M+6TRJT982E+$8N5/"X;"QOFF(G4A5I9-4>+QV#5#'+"/$5*M7VF68Z<O[,IY
MA2IT<-4J5:L$K/:G!U'AXT>6<\PC"IDE-3C">>4I5*U&5;+O:.G&G0A7H5:$
ML1F4LOH2G[&5.I4I8S!U,1T-O^T]X-N9"(/"_C5K5?B[X2^$"WX_X0D6DNH^
M._#^A^)O"?BRU4>-C=WGA'6-*\2:-,OV2UG\667VIWU+PG906=_-;:K!8A5L
M!AJD%A\3CX\3J%"K*/M*&)X46:2S+!XCV3J0C7JPRC&SPE2C.M@Y\M.&(Q6&
MJ580?-B<11PN 691E]8P<\MX=S:A5PZ;5? \2YC3RK!UJ<:JI./U;'U50QL*
MRI35I5<(L91Y:DN3A_:^T?49?&&GZ1\(OB^NJ>%#\1])1]9TWP-I>A:MXU^&
MMKJM]K/@W3-:;Q_+:ZA?2Z?I4NJPZM8^?X8BM)4L;[7[+Q"LVB0^57KN.2U\
MVP[IQ4,GEG-"EB55IS>#I8S 99C\3.E"//['*<QS+#X?&\K4L;R8BID?]JT:
M3K'I2P]/#YO@LJQ%3FJ8O,\%EJ>%3FN?,<IQ.>9:XSJ1ITH3S3+,)6JX6G6E
M3JX:<J"S:EEU.O3G+Z+^'/B;4_&7@3PGXJUCP]J'A35-?T+3]3O= U.31I;N
MPFN[=)6!?0-=\2:7]GN01=V:PZU>S)9SP)>F&]6XMX?8S+"T\%CL5A:4W*%"
MM.$>;^)2L_>H5VH0IRQ&'=Z&(E0Y\-*O3J2PM:OAW3K3\;+,5/&X#"XJ=-4Y
M5Z,*GNV]E54HIQQ&'7-*I'#8A-5L/'$1HXJ-&<%B:%"NJE*$GC[Q8/ G@_7?
M&#V*ZC:^'+,ZKJ-G]O@TZ9]*M9(Y-4>RFND-M-J4.GBXFTW3YY+2+5+Z.WTY
MKZQ^U?:X?.J58471=15/95,11P\G1I3Q%>,L3-4*+HX6DG6Q4GB*E&,L/AXS
MQ52G*;PE#%XI4<'B/2ITI5'*$'",U2JSIJI.%&DY4Z<JEJM>I*-+#4FHOGQ-
M:4:%!?O<1.G0C4JP\UUCX@:GXO\ V?O%WQ&\*7>I>";NY\$>+/$7A/4K9=%U
M'7=,CTRQU"ZT>]O]+U_1-6T>QUB3['&=5\.:MI>I2:/.\^E7X&HVTZP89U[?
M+L#*JJD88BC0PN,FL-*CC:#C4=+$JC1KTE6HXZA6PTX0EB<"Y4JZJ3GEN*K4
MOJV.J[Y(L/F&:8?"N$WAJN9?V8W5C/#5T_:K!8FM[%M3PU6ABO;RPU/$IS<:
M5"ICL+2G4KY?2^;_  O^TGK/PST#7/%GCV]^,OQ'^'/]D^#7TGQ5\2OA]X*^
M!_B.'QCJ-KKU[XPTJ&X\=:%^SCX*;P3I6EV>@76E:_K%O9'4M:U:3P_H6N^+
M-4N+?3+#UL?+"8)5:52-/#NGF.81PE7VSEB:^4X58*G[?'8%U)8F.8+'XMX7
M"8# X59GCZ,:U:.31H8&KC\3YV!A5Q5#+JM.I.IB,3@H3S##TZ+G@L+BJL85
M<*\%C*-*5+ZO5P]+-,1F&(Q.+JX# T<'@ZD\PI3S"CAY^TR_M1Z)<>(M.\*^
M&?AC\5O%>J:W\+]*^+NB76CZ9X.@T&[\'ZSI6JW]G<WNMZOXVTRUT&[&H:8G
MA][#7AIMY=:MJ-K)I$.J:1;ZKJNF\F8TZ^70XEC)4X5^%ZF)P^.564HT55I4
ME/#RI5(Q?UBGBVL2X4J"GC:=/ 8NKB<+AZ;PD\5TY=[',*'#V+IUHT\+Q'45
M+ RY9SJQG"M@X8N-:C3C)P^IX?'X7&5:]W@YTJ].A0Q57'36$,7PU^TND^A>
M!?%'CGP;\1_!UYXE^$=EXWA\.Q6_PZU;0M?U#6O%'A+PO96.D?V%XK\2>)4U
M^ZU;Q)H(\-VU]J.DZ&^A^+8V\0R1Z[8WMKX?]#'8)X+&YQ@</">+KX+,,ER^
MGA6E'%QK9C'/)PITI<]+ 1<7EF,I9Q6Q6*EA,-/+J-; 8GZE4Q&+Q7'AJ\<7
M3R[$0E[&ABL-Q'C_ &D.>=&&!R3"9?C\37Q7-06*DJ.$Q+G@XX/#1Q%>I#'1
MQ.&5\OIRL>(_VG++PDFM^(?%?PS^.?A:W\(?#KQ3XUU[PKJ6E?"I8WTKPUXB
M\/Z=XCU"">'QQ>3:QJ?AC3]4L]9AG\-^)+GPIK&@ZIJ%MI,_B3Q=8#1M+X4Z
M4*->LZE.5'ZYPYA)5'#$*I@Y9UB,\P5"HL-"E'%>SJ8[+J^%QL:V'KXB2PV7
M8W**-7+,;/'8S>"J5J^&PU.G5CB9T\_J4L/:G%8R659?E.8QI*O-O#.>)H9A
M2CETJ.)HT:.+EC\'GU; XC"*C0IZW^V=\/?#G@B?QQK7@SXC:+;6MS;&?1O$
M4/@#P?JEOHNI:7;ZUHOB.[O_ !E\0?#WA.PLO$&F7=K-HNAW_B:U\;WUY-_8
MJ^%$UZ*XTN%5TL+B*>%K-4ZWM\5A,9"%Z\LNQV"^I/%X"K3PRK5<?C:-/,<'
M7^KY'3S:=:A5G6H*K3P^*E1K#6Q492PWOPE2PF(PE3X*>-PF.J9C1PV-I5)\
ML,)@IU<IS"$L7FLLNP\)4:?/4BL9@7BO3/!OQ>U3Q?\ %7Q1X&M_ >OV7A31
M_ 7@/QEI/CJXN?"HTS4F\9#69TM9+*'Q;/XFMVG@L1!I\<OA:%8KO1M??4[R
MVMKCP\^J=+PM2EA\SG7M1Q&6Y_C<D^KW4GB98/!9=B:DJ$X<U-3A+'1J3]O4
MP]-X;$X+V3J8E8^A@^>.*H5%E,L++VL,SRBCG#LIPGA:&*Q&+H8>-:%2%.%[
MX*HIO#U<3)U*T(\D*5.5:IQ4'[2FC:5I5Q<-X-^,'B:YLM4^(]_XILQIGPW?
M5/A_X9\#^-M4\,:[K&LG2_%6DZ/J/AO1KVTFMM"L?"]SXP\?ZOHMHEW/I&K:
ME%J,]84O9SCA.:K0PU"66Y'BL1CL1.5.CAIY['%_V?3S"RE.&*JU,#C:>+K8
M+#U,IP;PTZU;$T,+4HUZWH8C#U:>.G@:=%3QE6M[# 8'#/3'JAE638R=?!5<
M1.-.G3Q5+.,LQ/)F6)PE>6+S-X>CAZ-.E+#82[H/[4GA;7_B3=_#6V\ ?%&T
MN=.\8KX'U#Q=>:-X8'@:UUN_\.MXM\-A-<L_%]Y/J$/BKPVHU?38](T[4+_2
M8);6+QC8^%[N]L[>>L/0J5J=.<E]4E56:0I4<5>%:IB\EKXJCFN!A"FJBE6P
M:PE6M/$)_P!FU8IT</CJV,A6PM/CK584=:5\326'RK&NMAK>RAE^=/+Z6 QT
MU6=&I"G6QN94L!]7E36/]O2Q&(C@Y9;3CCYW/VGM;\;^'? OA_4O .O>/M&U
M>3XA^#-'N;/X:Z?\*]0\5^(-*U[5%TF_T?2X_C#HVJ^#H;QHKK[99374^DLM
MY:0*]]);O-977$YN&/R^$EB)8>K3SMXBCAH4I5.7 \.9OG-*O&,X^T?L*V5T
MW5IT92J5L'4Q=*CAZ^,EA'3UJR5+ 8VI%X6G6IULEA1JXIUXTX/'\191E-6E
M^Y?+&=>AF-2%"I6C[&EB_JU7$5:.%AB9/QS2OVH)OA!\)=-\>?&5?'OB#1?$
MVJZMJ?A+4?$#_!#0_&^F>![&RT42M\2+O1O$W@/X4GQ>FO7FHVFF>#? LU[X
MRU.Q-CIUKX7U7Q!IGB'[/ZLZ=*>+RC+*2PRQV+IX6G5JX.M4K8"M5S''5XY5
M4P:E.MC,?*MECPN)QU;*:&-P,9QQ.,PTH9;4PE2K.&HUJ]/,,325:-'#8F.$
MAAL;+"X?&?7:7MJ.-I-KV.%R_!T\5AJE*G4SK$8.5"LUA\=B*>)K4<-'O?%G
M[5FE?#S5_B?+XY\%^(-$\$>!?^$"M-#\73ZQ\-M.TWQ5K/CBWCFL=,CO->^(
MVD0Z"]V]U&MM?^,8?"OAZP@T_4;G6O$%EYUC#)YT*D8TJD:KC2QBXCS#(J&%
ME4I4_:1R_*,/FM:JJM2<<-ST</[?%U(O$QJ8C#XS*\)@*&*S3Z]A,/"J<U2C
M*A&=3!3X>P.>U,3"E4FZ"QV9XO+J-.="G&6)E&O7A1PM*5+#U%0Q.'S&OCJF
M%RV.#QN)]Y^&7Q'\+_%KP/H/Q!\&78O/#WB"&YDM)1<:==F*>QOKG3-1LWN]
M'O\ 5-'NY+'4K*[LWN](U34]*NF@-SINHWUC+!=2]N*PM3!U(4Y[5,/A<90G
M[.M257"X[#4L9A:RI8FE0Q-+VN'KTYNEB*%'$4G)TZ]*G5C.$<\-B88F%1QC
M*G.AB,1A:]*<J4I4<1AJLJ-6#G0J5J%1<T>:G5H5:M"M2E"M1JU*52$Y<IHG
MQA@UGXKZ[\(X]!>WUOPS!=:IJ^I-JUK)I)T.2#3Y='FTIT@%QJ6N7+:I9C7O
M#I@M9_"D#PWVIW;V.M>$KCQ+CA8/$87$XM6IT\)46%JQOS3>-J8BK&E&E%)*
M6"EA</7JSQ[<81QL?[,ITJV)H9B\OZ,7_LE?!X>W.\=06*HRUIJ.&A3E#$.J
MFO<Q$,='V.'P\7-8G!-YA[6ERO#&Q\0)'C\0_!Y4@EE$GQ+G1VC,*K;K_P *
MU^(C^=*)9HF,>Y5BQ LTWF2H?*\H2R1K#_[VXVY5_9N8/FT2BU/!VBTO>O/:
M-HN.CYG'2^DGRY;F=DW:.3KE5D[2XER1.6KBK13<Y:WY4^52E:+\(^(UW^RE
MXH\6ZI<_$K]GO6?'WBO2IYM N_$6M?L0_&/XB23)H]S/:K#IOC!/@AK]CK>C
M1RB9],O]'U>_T6\MY1>:7=7%I<1SR94Z<*$ISI0A1G4J*M4E3BJ<JE50A356
M<HI.=14Z5*"G)N2A3A&_+"*4RG.481E.4HTH.G3C*3<:<'.=1P@F[0@ZE2I4
M<8V3G.<K<TI-Y-MJO[(-E<QWEG^S?XCM+N#7K3Q5#=6W[ OQT@N8?$]AO^P>
M(XYXO@"LL>O67FR_9-85AJ%MYC^3<)O;.T*E2E*$J=2=.5-8V-.4)2A*G',H
M4Z>8Q@XM."Q].C1AC5&RQ4*5.-?VD812SE"$^;GA&7/0PN%GS14N?#8&%2E@
ML/*Z?-0P=*M5IX6D[T\/"K4A2C",Y)P75W^QQ>IY=Y^S-KEW&/._=W7[ 'QQ
MG0?:=3?6KCY9?V?W4?:-9DDU:;C][J;O?ONNF,IBG^Y=)TOW3H+#*@Z?[MT5
M@H5J6#5)QM[-82GB,13PW);V$*]:%+EC5FI74;J>T55NI[:I7JU54?-[6KBH
MT(XJI4YK\]3$QPN&C7G*\JT</051R5&GRP3W'[(GV6:'2?@#X[\+7V[7[C3O
M$'A']AGX_P#AGQ-X?U;Q/I\>F:UXA\-Z]I/P%MM1T+Q'?6D-LDVN:?-#J$IL
M[/SII!;1*LS4W15"%:K0A#"_4::I.*C2P3J5*LL$J52%2A+ U*E:NZV!JTJF
M#Q$:]>%>A4A7JQGI1J^QK4:SITJWL,5A\8J6(IJK1GB,+4C5H5:E.6DITJD5
M*G4NJE.24J<X32DI?A3XN^%'PIN-;O8+S]J[Q?J.NVVDV%Q=^)?V1?C9HT-K
MI^AI<KIUM::'\-?V9/A_X9,\?VRX\_6;S0[OQ#>1&WM+S5Y[&QL+6UZIXB3H
MNE[.G%U,34QE:JO:.I6Q-6$*4JC4ZDJ5!>RI4X>RPE+#49\D:E2G.M>H^94H
MQE0:;C'"X>6%P].T?W="5157"=9Q>*Q'+.-Z?UJO7]BYUI4?9RQ.)E6]2UKX
M]?"#Q'I-_H/B+P)\;->T/5;:2SU/1=:_8_\ VG-4TG4K248EM;_3K[X*SV=Y
M;2#_ %D%Q#)$X^\IKG7NSI3C[LZ%:CB:$UI.CB,-5A7P^(I26M.MAZ].G6HU
M8-3I580J4Y1G&+6J;BI*+<5*G4I32;2E2K4Y4JU.26].K2G.G4@_=G3G*$DX
MR:?->(_B1^SAXPO+?4?%OP9^(_BC4+32-0\/6M]XC_8B_:(UN\MM U:/R=5T
M.WN=3^!=S/#I&IQ$Q:AIL;K97L9V7,,B\5+A#FKRY8\V+C3ABI.*YL3"C55>
ME"N[7K1I5TJU.-3F4*J52*4TF$&Z2PL:3=.."J2K8*,&X+"5I4E1E5PJC98>
MI*BE2E.ER2=)*FWR*QST6L_LBP:==Z/!^SEXFATF_P!9L_$=_I<7[!'QVCTZ
M]\0Z<KII^O7=BGP"%M<ZS8I)(MGJDT3WUJLCK!.@9@=%.<9X>I&4HSP>(K8K
M"34FIX7%8CV?M\3AY)WH8BO[&E[:M2<:E7V5/GE+DC;-TX<M:#A#DQ&#PV7X
MB+BN6O@,'&4<'@:T;6JX/"QG..&PTU*C0C*2I0BI.]B;Q+^RA<3:%/<?L^>+
MIY_"^JWFN^&9IOV#_CW)-X=UO4=3&M:AK.A2/\!&?2-5OM85=6O-0T\V]W<Z
MF!?SS/= 2T49SPM2C5P\I8>KAL+3P.'JT9.E4H8*E"=*E@Z,X.,J6%ITZE2G
M3P\'&E"%2<(P4923N?[RE7H5/?HXJM+$8FC/WJ6(Q$J:HRKUZ<KPK5I4HJE*
MK44INFE!RY4D>H_\-+?#K_H7/V@/_$3OVI__ )S=2!1U/]H'X3ZU8W&EZSX*
M^..K:9=*JW6G:G^R'^T]?V-RJ2)*BW%G=?!>6WF5)8XY5$D;!9$1QAE!$3IT
MYI1G"$E&=.I%3BI*-2E.-2G42::4Z=2,:E.2]Z$XQE%J23&FX\RBW%3IU*4D
MFUS4JU.5*M3DE\5.K2G.G4@[QJ4YRA).,FGP<'B[]EBT\+W7@BU^ GC6V\%W
MNIQZW>>$(/V$_C]#X7N]9BN(KN+5KK0(_@,NDW&IQW4,-S'?RVCW27$44RRB
M2-&&L92@\$X2E!Y9-5,M<6XO+ZD7-QG@FK/"33J5&I4/9R3J3L_>E>9).6-E
M))RS%2CF$I*\L=&HHJ<<:WKB5-1BI*OSJ2C%.Z2*>H:]^R3JW]H?VK^SMXIU
M/^UM3N]:U7^T/V"OCQ>_VEK&H6$NE7VK:A]I^ <GVS4[W2YY]-N[^Y\RZN;"
M:6SFE>WD>,Q%*G"G2@E"G2C5A2IQ2C"G#$5Z6*KPIP5HPC6Q-"CB*L8I*I7H
MTJLU*I3A)4V[N3;O*-"$FV[N&&A.EAXM[N-"G4J4Z$7I2A4G"FHQE).]>^,O
MV7-0TWP_HVH? ?QO?:/X2T[4='\*Z5>_L*_'^YTWPSI.KV;:=JVE^'[&?X#O
M:Z-IVJ:>[V&HV6FQ6UM>V;-:W,4L#%#51NK5JUJK=2M7P\,)7JU&YU:V%IRI
MSIX:K.5Y5,/3G2I3A1FW3C*G3E&*<(M.A.>%A"GAI2P].GBECJ<*$G2A#&QJ
M3JQQD(TW&,<4JM2I56(BE652I.:GS2DWSBG]BZ.WN[-/V7M5CM-0M;&QO[9/
M^"?7QM2WO;+2Y89],M+N%?V?1'<VNG3V]O-86\RO%9RP0R6Z1O$A5QG4IRA*
MG4J4ITL11QE*=.<J=2CC,/1JX?#XNE.#4J6*P]"O6HT,1!QK4:5:K3ISC"I)
M..6/N>[']U1KX>GHOW>'Q6)CC<30AI[E'$XR,<77I1M"MB8JO4C*JE,H>!-6
M^#W@/Q@?%]MJ'[7&NO;IKL.BZ)K7[)WQOMM,T2#Q'>?;M3@_M#PQ^S)X;\6^
M*$>98S;O\0/$WC":T:*.X@E2]W7++#2EA:$Z-Y5ISPN%P4\36D_:SP^#E3E0
MYZ=)TL'/$0=-)XZ>%ECY*>)4L4_KN-^L*O"%6K2J1A'#4Z.(J8FGAL.N6C"M
M5HU*,E3E4]KB*.%Y:U3DRZA7I9;3:PT:>#C3R_+H83V;6OCS\'_$>FW&B^(?
M GQKU[1[LPF[TG6OV/OVF]4TVZ-M<17=N;BPOO@K/:S&"Z@AN83)$WE7$,4R
M;9(T8)+EJ4:J]VKAJ]+$X>HM*F'Q-":JT,11FO>I5Z-2,:E*K!QJ4YI3A)22
M93^"K3?\.M1KX:M!_!5P^*I3H8G#U8_#.CB*%2I1KTIIPJTJDZ=2,H2DGS'B
M3XB?LV^,;^35?%WP6^(GBG5)-%N?#<NI>)/V(/VA]<OY/#MZ_FWF@27FI_ N
MZN'T6[E_>7.E-(;&=_GE@=N:4(JE*K*FE3E6J8:K6E!*$JM7!U%6P=2JXV<Z
MF%JQC5PTY7E0J14Z3C))E<TN6E!RER4/:^PC=\M'V]-T:_LH[4_;492I5>1+
MVE.3A.\6T8D.N_LDVUDFFV_[.WBF#3H_$J>,TL(?V"OCQ%9)XPC01Q^*TM4^
M :P+XE2,"--=$8U14 5;H* *OGFGAWS23PD*U+"OF:>&IXGE^L4\.[_N88CE
MC[:%/EC5Y8^T4K(CECR8FGRKV>,ITZ.+IV7)BJ5*4Y4J6)C\->G3E4J2IPJJ
M482J3<4G*5Y9/$O[*$@\,++^SYXOD7P1=SZAX,63]@_X]L/"-_<ZE_;-S>^&
M WP$(T"[N-7_ .)K/<Z5]DFEU+_3I':Z_>TZ52I0K4\11J3HXBEA:.!I5Z4I
M4ZU/!8>A]6P^$IU8-3AA:&&;P]'#QDJ5.A^ZA"-/W2JLI5J>)I5I.K2QF(JX
MS&4ZK<Z>*Q=>ZKXK$PE>-?$5E*7M:]52JU.9\\G=GT.)'_X7"T/V>81CX:I)
M]JW0>1O/BAU^S[?/^U>=M_>;OLWD;.//\S]W66%^+/->7E_U723NG+F7%UW&
MRLE#E2ES.+?/'D4TIN$XKW99%;K'BJ]M.7E?!MN:]OCYGR\O-;V<^?DO#GRO
M@O$\6A>, ]Q-<%OBW\7)%,RVZF))/B!KS+!&+>"!3%"/DC,@DG*@&::5\N:H
MZ9;D\>L<OLY;2D_KN-?-)*T5)W2]R,(V2]V]V]<6K9KF>KMRY"U'1*"_U1X=
M7+&R3LVG+WG*7-)Z\O+&/K]!F>/_ !"^$DOC?Q5X2\:Z/\2OB!\,O$W@[P_X
MS\+6>I^!;?X<7O\ :.A>.]1\#ZMK=CJEE\2/AY\0=/;;J'P]\.7%C=:=::;>
M6_EWD3W$T%TT:@'/_P#"F_B+_P!'8_M ?^$Y^RS_ /0TT '_  IOXB_]'8_M
M ?\ A.?LL_\ T-- !_PIOXB_]'8_M ?^$Y^RS_\ 0TT '_"F_B+_ -'8_M ?
M^$Y^RS_]#30 ?\*;^(O_ $=C^T!_X3G[+/\ ]#30 ?\ "F_B+_T=C^T!_P"$
MY^RS_P#0TT ?//@JU^-'B+]H_P"./P?O?VI/C+#X:^&?@_X1^(-!OK3PG^S/
M'KMW>^/H/%<NL1:O<S?L]SZ?/:VS:%:#34L],L)81)<_:IKPO$80#Z&_X4W\
M1?\ H[']H#_PG/V6?_H:: #_ (4W\1?^CL?V@/\ PG/V6?\ Z&F@ _X4W\1?
M^CL?V@/_  G/V6?_ *&F@ _X4W\1?^CL?V@/_"<_99_^AIH /^%-_$7_ *.Q
M_: _\)S]EG_Z&F@ _P"%-_$7_H[']H#_ ,)S]EG_ .AIH /^%-_$7_H[']H#
M_P )S]EG_P"AIH /^%-_$7_H[']H#_PG/V6?_H:: #_A3?Q%_P"CL?V@/_"<
M_99_^AIH -/^!>K#Q?X$\6^+?CM\8/B'_P *[\0:EXI\/>'O%.G? [3-"&NZ
MGX)\7> 'OKY_ 'P7\$>(+G[-X?\ &^O+:VJZ]#9_;)K>YN;>Y^S1QT!M\OU/
M2++X=>%=.\=>(/B1:0ZVGBWQ1HFE^'=9NI?%WB^XTF;2-%>>72K:T\*W.NS>
M%-)DLIKN^GAO=(T2QOA/J.J3-<M+J=^]RH+V>%Q6"A*<</C,4\;6BZDW4CBG
MAXX657#UY2=?!\^'A2ISAA*M"$U0PSE%RPV'E3JK)U*F!JS?O9=0KX?"QC^[
MI1IXFO#$5_;4(<M'%5)U:</WV+IUZT:<(T85(T8JFN"A_9O^%-MX9T?PC!:^
M.XM#T#QK<_$/2HD^,?QC74K?Q=>7-Q>W.IR:\/'O]OWD,U_>7FI-I-[J=QHO
M]I7=UJ(TX7US-</3;YL!+12RO+ZN5X%I*+H8&OAJF"E2T2]I.&!JU,!0Q%7G
MQ&&P$W@<-5I87]R1)1E/,9RC%O-,;3S''1Y8JE5Q=*K3Q$*E.BE[+#06*HT<
M6Z&%A1P\L91I8N5)XFG"K')M?V4?@?:1:1 ?#_BN^M]!T/7_  YI-OK7Q8^+
MNOV]II/B?58M=UB(0:YXZU&*:[FUNVL=8M-4N$EU72=5TO1]0TF]L;O1]+FM
M!-QC.$&Z2EALJPD?8OV$J%'(ZCJ90\)*CR2P5?+KRIX7%81T,52P\ZF%5;ZM
M4G2E2;2C&[Y8X_,,SG"3<H5\7FV$G@LREBZ<KPQE#'8>K76*P>+C6P=:KB<7
MB9X=XG%XFM5P/B%^RAX*\3>&-?T_PG?:EX=\7:QX&UOX=Q^*?&'B3XH_$[3O
M^$=\4RV@\3MXC\*:O\3](M/&FLZK9V=M;G7_ !+J-YK*2:=H37-[>V>A6&GI
M,G/F2BL/[">+RC$8O!U<-">$Q-/)LQ_M7#8=8>$J5+"JIC98BIB:V&C3K5HY
MAFSE/VV:8NO-TU2481FL1&5"&;2P=?"XF6%QF&Q>;97+*IXCZU[.K5K4\/A_
M8/#X.NYX:@\+A?JT,/*A2G#>T+]E;X+Z)I.@:?'X5EM[G0UO"UUHWBOXA:-'
M>#5M*L='UC1;B,>-+V_O? EQI^G6.G:?\/-=U77/"6CZ1I^EZ59:<+;3+3R]
M<7*&)GB+QJ2H8BAB<)4HXFK]9EB<-B9)REF-1TZ<,RS'W*<GFV*HRQ_MJ<*]
M.M2J1ARY855\/1HP=9*M2KX#&^UPL)X.G3QV7O&3H5<!1A5F\MP\:N99E46"
MPU58=K,,7&M&M]8K2J=KX ^"?P_^&.K:AK?A"W\5P:CJ>A:)X:O)-?\ B3\2
M?&EN=$\."9="L8+#QIXM\0:?9C3$N;E+6>SM;>Z2.ZNHS.R7,ZR5[>M[.O2E
M-SCB<9_:%=U+5*M3&O#T\+4Q4JTU*M[:O0HT(8J:FGB_J^&GBO;3P]"5.?84
M54PU6%*G1EA,)5P.&C0BL/1I8.KC*F.^K+#T%3H.C0Q%:J\%"5.4<!1JU,+@
M5A\+.5%];XU\%Z!\0?"^K>#O%$>J3:!K<*6VIV^C^(O$7A2^N+9)HYS;KK?A
M35=$URV@G:)8KN&UU&".]M6FLKQ9[.XG@DR@W2KX3$QTJX'%X;'89[PABL)5
MC7P]2=*5Z594JT858TJ\*E)U(0G*FY0BUT0J.FJL4J;C7P^(PM6-2E2JQE0Q
M5*="O%1JPFH.=*I.*J04:D.;FISC*S/./&G[.?PI\?ZEK6K>*=/\87-[XAL?
M"VFZN=,^*WQ7\-6UW:>"M2;6/"P&G^&?&VCZ?;3Z/JSR:E;WEI:P7DE]+-=7
M,\TTTKN46\-5C5I-QG#-89W!-N4*>9PPRP<<13I3YJ5./U>-.G+#PA'"S]C0
MG.C*="C*$;1I0N^6CEF*R:*YG[V6XZHJF+P]=WOB'B/>I5:V(=7$2PU2MA75
M^K5ZU*I@K^R9\#?M7VJXT+QCJ1_M'Q9JSVFM_&'XR:]I,VH>.8%@\57-QHFM
M>/[_ $>Y;5E599$N+&6*VNU%]9);7H%Q2I)4(4J=)*G[#"QP6'G!*%?#4*>8
M4\VI_5L1%+$8:O3S2C1S"GBJ%6GBJ>,H4,3"M&K1I2B5%[5R=7]YSU:5:I&K
M^\A6G1P,\KA[>G.\*]/^RZE7*Y4:T9TJF65JV7U(2P=:K1G>U#]ESX(ZMH5K
MX=U?POK6KV%OK&H:Y/=:O\0_B3JGB#6[S5K"VTG58/%GBO4/%]QXI\9Z-J>D
M65CH^H^'?%NL:UX?O='L-/TFYTR73[&TMH2KRU)T)U*=%_5L+5P=.FJ-*&'>
M'K8NEF%6-;#0A'#XFI/,*-+'NOB*56O]>IPQGM/K,55*A.I2A4A3J58<\J$H
MU%5J*OA98:AB<-AWE^)YOK&6NCA\9C:--Y?5PW+3QN-BM,7B?:YP_9)^!BZ.
M?#T>A>,H-!'@6;X9KHUM\8_C-:Z9%X$GU)]5D\-06-O\0(K>WL!<N88C!''<
M0:6L6B03QZ-##8)=2I5J5*M6I5JRKUJN45ZN(E5J?6JE?(8P64UYXGF]O*OA
M)1E5]LZGM:^(KXO%8F5;$8W%U:Y3DZ.(IXFC&G1JT:F:U**I4J5*E0EG<9QS
M/V.'IPCAZ,,3SQE[.G2A3HU,/@JN'C2JX#!3P_JOAGX:>$O!VN:IXBT"#7;;
M5-;TW1=,U=KWQEXRUFQU&/0--L]'TS4+O1]:U_4-'F\0II>GV-A>>*6L/^$E
MU6UM+>+5=6O5B0"Y5ZC6(BW'EQ.-JX^I%4Z<84\37<I5_JL(P4<#0K3G*I4P
M>"6'P<ZK]M*@ZJ4UA"C"G# 4XNIR9;@%EF#4JU:3A@HUZN)A1JRG.4L4Z=:O
M7G2JXIUJU+VU:-.I&%6I&7>UB:F;;Z1I]IJ>HZQ!;^7J.JP:?;7]QYL[?:(=
M+%T+%/)>1H(?(^VW7S011O+YO[YI-D>PA^[ISI1]VG/$U,9*/?$U<-@\)4J7
M>JYL/@,)3Y$U37LN>,5.I5E-.*]HJK7[R.'I812U5L/1KXO$TZ?*K1]VOCL5
M/GMSR]KRRDX0IQAX;\&9);KQC^TW!//</''\<8K:%?M$RM;P-\%_A$YCMG21
M9+90\LDB^0T921VE0K(2U9X:/M>'LJA.4[3K<7TI2C4J4ZBA_KQQ13BH5:<H
M5:;A"T:<J<XRIV3IRBXIJ\3)T\[KN"BE#*^&ZD8N$94^=Y>I2<J<U*G+GDDY
MJ<7&>TU)71OGX!_#/_A6DWPA-GXN_P"$$N+^74IK%OBA\43KCW<^L?V_.3XU
M/C+_ (3<6\^KEKV:R7Q$+*5Y)8WMV@EDB;6;<I9;)J,7D_U'^SE3C&E'#_V;
M%0RZ\*2A&M]0C&DL)]857ZN\/A72Y'A,,Z6<(0A_:"C"/+FDL9/'PE%2A7>8
MMO,+0FG"BL>Y57C(T(TXXIXC%NNJCQF*]ME^+?V:OA-XW\2P>+O$=IX\GUZW
MMO"]HESIWQF^,WAZU:+P7?MJOA8W.D^'O'^E:1>7&CZM)+J]M=W=A-=OJT]Q
MJEQ--?W$UQ)6'J3PF*GC*#]G7GC)X]JT948XFIA9X*I*GA9J6%I49X*I5P<\
M+2HPPLL)7Q&&=%T<16A-5H+$8&GEM9SE@Z.%JX.$/:U(U%1KU*-6LY8F,XXF
M>(JU<-A*D\94K2Q<IX/!3=?FP>&=(C_9H^#T)9X]&\4)<-XGU_Q:]]_PM#XI
MG5)-3\62VMQXIL)=5;QH=2E\)>)+BRM+G7? <ETW@?5KFWAN+_P[<3('J:+6
M'HX7#TX4UA\'@W@*="I2IU:-;"NO7Q,:>/I5HSIYG*CB,5B:^'K9E'%U\-6Q
M%>IAZE*=6;EO*K4<L1-SFJF(J4*TJD9.%6C7PU!82AB,'4@XU,OQ%+"1A@XU
M\#+#5OJ=*CA'-X>C2IP\\\5?L?\ @?7O$7A2:RG6S\$Z3XN\4>//$?AK5]2^
M*&O^)-0\7^(M.M=/M]:\"^/3\6=,U#X52Z3':1BWM?#.E360MVDL[.WT^WDD
M5YP\84J].K63KT\)E6/RW 4[J-6F\US*EF>9UL?B:L:]3-Z685:,J>-PF.YZ
M>-I8[-8XV>)_M"?L\:L(NC*G1C##SJX_ 8S%6IP>'J0RS U\NP%&EA(JE2PD
M\'AL2_JF)P_)6PE7 Y++#>RIY52I5/0O^&9?@Q'<"XL?#6LZ&8K[P]JEE;>&
M/'_Q%\*Z=I&J>%]'B\.Z/JF@:5X;\6:5IOA[4U\.PQ^'M2U#0[33[S7=!!T7
M79M2TQWM6UE6K2E.4ZM64IU<QJRE.I.4E_:WM99C1A*3<J>$Q=6O4Q57 TW'
M!_77''1H1QE.G7A22491LK3HX>A6NDWB8X7$4L5AJF+D[RQ>*H5Z-.I2QF)=
M7%PY7&-=0E.,O2? /@+PU\,O"^G^#/"$&K6OA_2FNVL;;6?$WB?Q=?0?;;J:
M]N$.M^+]8UW7)HC<SRO%#/J,L-LK^5;)%"JQJ3JRG&A!JG".&PV'PE"-.E2H
MQIX?"THT</2Y:4()JE1A"E"4DY*G"$.;EA%*(PC"=>:YN?$XBMBJSE.<W/$8
MB7M,15]^4N6=>JY5ZSCR^UKU*M>:E6K59SEU3P1X?UCQ1X=\8WZ:NVN^%+36
M;+1'MO$WB;3M*@AU^WCM=3:\\.:?K%KX<U>ZD@B1+:^UC2K^]T[!;3;BT=W9
ML8PC!XMQ3C+&X+^SJ\KOF6$^LTL6Z>'DWS8.<\10H5*F(P;H8BK[&C"I5E3I
M0C&JD54CA8RORX/&?7Z$8MP2Q2P];"*I64'%8F$</B,13A1Q/MJ$/;UI0IQG
M5G*7A]U^Q[\![VSCL+O1O'T]G%X=\2>$TMY/CE\=2A\.>,-5&M>*-(D/_"R=
MTMIKVII%<ZFLI=[H6]I!(YMK.UAAJ#=*,84I3I1A3R>E!4IRI<D.'YJIDJCR
M.+B\LDO]DFK3I1E.$9<E2I&6TJU3VRK^[3JQS#,\U4J5.G12Q^<8>6&S&NH4
MHP@OK-.I.7LN7V-*O.6+H4Z6*DZSM?\ #)/P-^WZCJSZ)XVEU75S;C5M5N/C
M/\:KG4]3MK?2[#19=,U#4+CXA27EYHFJ:5I.D67B#0;B:31?$T.CZ1_PD-AJ
M;:5I[6VJJS2<+4Y4I8FOBZM"=&C/#5ZV)KO%5/K6%G"6'Q5&&(E4K8;#8FE5
MPV$J5L1+"4J/UBO[3*+E3A2IPJ5H1PV&HX7"N-:K&>"I8?VKHO U%-5,#6I_
M6,0EBL).CB7&O7BZSC6J*6CXE_9;^!?BSQ3%XSUOP7</XBMK_0=7L;O3?%_C
MG0+72]<\,II-OHOB+1]'T#Q+IFC:-XEM+#0]*T:3Q)I6GV>NWOA^S3P[?ZA=
M:&\VGR*C6JX:L\12JU(U_K&)Q*K2G*I5C/&JK]?I0G5<Y4\'F,J]6IF. @XX
M',:TO;XW#UZT8S6>(I4\3@X9?6BG@Z6"I9?3P\;TH4\+AYXBIA(Q]DX257 U
M,7B:F7XE/ZUE\ZTY8*M0D[DEE^S)\'["]L;Z'2_&4LVFZ_XR\3VL.H?%SXO:
MK8#6OB#:R6?C&YN-*U3QU>:9>PZY!/="?3[VTN--MY;[4;FRM+:XU&^EN,'3
MA]5^I2A%X?\ L6KP\X32G*645ZWUBKA)U97K3<JZI5OK,ZDL7&KA\).-=2P>
M%='IJUJE7$1Q=27^T4\QP6;4ZL8QINGC\NH_5L%7I*FHQI1PV$;P5.A3C'#_
M %"4L"Z3PDI47ZSX1\*:/X&\.Z7X5\/G5QHVBV_V73DUSQ)XC\6:E%;!V>."
M77O%FJZWKUY% &\FU2]U*X%I:I#:6PBM8(88^FOB*N)J.K6DI591BI34(0E4
M<8J/M*KA&/M:]2W/6Q%3FKXBJY5J]2I5G.<N2A0I8:'LJ$?94E)N-)2E[.DI
M;4Z%-R<,/0@K1HX>BJ="C!*G1IP@E%;-[I]AJ,*VVHV5I?VZ7-I>)!>VT-U"
MEW874-]872Q3HZ+<V5[;P7EI.%$MM=0PW$+)+&CKE%N,X3BW&=-R=.<=)TW4
MISHS<)+6#G2J5*4G%KFIU)P=XSDGMLI1VC*+A*.RE"7Q1DMG%]8O1]4<]KO@
M?POXA\,>(?!U_IC6OA_Q5#JL&OVF@7^I>%;J_&N-(^L3?VMX7O-'UBTO-3>:
M9[Z_LK^VOKEIIFEN&,LA;"MAZ5:C##58MT*;@X4HSG3IQ5.M]85/EIR@O8RK
M7G5HN]&MSU(UH3A4J1EM2KU</7^M4IN.(]VU=J,JJE"A#"TIJ<E*4:M"A3I4
M\-5353#*C0="=.5&DX<WJWP<\!:WI7@G1M2LO$$]I\._)'A6XC\=^/+36+:*
M+33I$EKJWB&S\2V^O^*+'4--)L]:L/%.I:U9:[$3_;5O?L=U=&)E];QF(QV(
MA2J5\7AL;@\4O8T8X?$87,)4:F+H5L%"$<'.G5JX>A7494&J6(HTL11]G6IQ
MFN>C".&PT<'07LJ%.M1Q%!1;57"U\/[;ZO6P>(O]8P52A#$5Z-*>$JT94\-6
MJ86+6'G*D\GP7\ ?AA\/=8;7/"VG>*+6]/A.#P*L&J?$KXF>)='A\)6EY<WV
MGZ';^'O$WB_6- M;/2I[R[71C;Z9%-HUI=W-AI<MI8SRVSE:<J^&S#"8B3KT
MLTE2GCWB/W]?$U*6%>"56IBZO-BE6JX=N.)K0K1JXRHY5\7.M7DZKJ'[J>%G
M2_<?4:^)Q.#IT/W%#"U<74A5Q'L,-1Y,/3IU9TJ#="-)48K#86,*<8X7#JEA
MP?LN_!>!-,A?0_%5_;:+X4O_  1I-EK7Q5^+.O:?IOAC4-1M]6DTZST_6O'%
M_90/9ZC8Z9=Z+J$=N-3\/2:+H']@WFFKH&C+8NI4JU)8B<ZM5U<7_9\J^(]I
M..*E6RNK*M@,8L7&2Q-/,,/5J5YK,:=6&/J2Q>-=7$5/KV,]N)1C]7C"E1IT
M\)6Q]:A0I4*-+#16:8-8#'X:6%IPCAJN78G")49Y75I3RU)*<,+&HN<Y?XA?
MLH>"O$WAC7]/\)WVI>'?%VL>!M;^'<?BGQAXD^*/Q.T[_A'?%,MH/$[>(_"F
MK_$_2+3QIK.JV=G;6YU_Q+J-YK*2:=H37-[>V>A6&GIG)SYDHK#^PGB\HQ&+
MP=7#0GA,33R;,?[5PV'6'A*E2PJJ8V6(J8FMAHTZU:.89LY3]MFF+KSJFJ2C
M",UB(RH0S:6#KX7$RPN,PV+S;*Y95/$?6O9U:M:GA\/[!X?!UW/#4'A<+]6A
MAY4*4X;VA?LK?!?1-)T#3X_"LMO<Z&MX6NM&\5_$+1H[P:MI5CH^L:+<1CQI
M>W][X$N-/TZQT[3_ (>:[JNN>$M'TC3]+TJRTX6VF6GEZXN4,3/$7C4E0Q%#
M$X2I1Q-7ZS+$X;$R3E+,:CITX9EF/N4Y/-L51EC_ &U.%>G6I5(PY<L*J^'H
MT8.LE6I5\!C?:X6$\'3IX[+WC)T*N HPJS>6X>-7,LRJ+!8:JL.UF&+C6C6^
ML5I5.]\*?!WP)X(U?3M;\.6WB6TU'2_"5CX'@>\^('Q UJUN?#>E75Y=Z3:Z
MOINN>*-2TW7KW2)+^]BTG7-<M-0UW2[*ZFTZPU*WL'-M52KUI+&*<W+Z_5I5
M\4Y6<IXFGAJ&#>+A)KFH8S$X?"X:&/QF'=+%9C*A2JX^KB:L(S4QH481P\*=
M*G2CA'7^KJE%4O94L16KUW@XNFHMY=0JXFM+ Y9*^7Y<I\N7X;#0C&,>+;]E
MOX*- ]M)H'B:6*?6O$&N7QG^*/Q6GFU:;Q9?PZKXFTC7+F7QL]QKO@_7M3@3
M4M6\!ZS+?>";Z_::\N/#[W%S<22QAJDL)]2]ARQ67X?"87#QG"%6#IX"OB<3
M@)XF%:-2&.Q67U\9BJF QN.CB,9@G7J?5:])2:-ZTYUZ];$U)SCB:TY5/;TY
MRH5\/*>%H8*:P-6@Z=3+83PF%PF&G2R^6&IRHX/!0E!QP>%5*_\ \,W_  G&
MMR>(18>,UU.3X@VGQ29D^+?Q<2Q7QQ8V+:7:ZK'I"^.5TB&SBTHKI'_"/0V*
M>&WTB&VTJ32'T^UMK:(PU2>$>#=)W>7T\TI81UTL4Z<,ZN\S4GBE6=9XJ<ZU
M5SK^TG2KXK&8BA*E7QN+J5LZL(5OK7-&--8W#Y;A<1##I82E*AE"C_9L8T<+
M[&E1EAG3H3C5HPIU:E7#8.K5G4JX/"SH]_XV^'OACX@P:%;>)XM;EA\->(]+
M\6:2NB^+?%OA)HM=T61IM,N;R7PEKFARZK;6LS>>-+U9[W299TBFFL9)88G2
M:+=#%X?&TO=Q&$6(5"4DJE."Q5">%Q'-AZG-AZGML-4K8:;JTIOZO7Q%!6I8
MFO"H58QK87$8*K&+P^)5'VT;*,[X>O#$T)4Z\>6O0G1Q-*CB:52A4ISAB*%"
MO&2JT*4X<)K?[.7PA\0ZY?>(-4\/:P][J4>NV]_9VGCSX@Z5X>N[/Q3#'%XH
MTZ?PGI7BFR\+/I7B:6&+4?$.DG1O[-US7(H_$&J6MUKB+J SIP5&E5H4W4C2
MK0C"4'5J/EC2FZN%]C*4W+#O+ZLJE7*I4'3EE%7$8JIECPD\5B95=W7JNO1Q
M//RXC#2P]2A7@HTZM.IAH^SA44X*,G4J453PV*G)N>.P>&P>#QCQ&%P6$HT)
M)?V>?A;,LPDL?&#/-H.@^'GN/^%J_%9;U;?PNP;P_K$5\OC47L'C/25416?Q
M!@GC\=QVY:U_X2,VS-$=9SE.I7JNU.KB<?\ VG4J48QH3CCI8%997K4)453E
MA5C,OBL)F-'#.C0S.@N3,*>)1S1HTH0HTXTX^SP^%E@J=*24Z?U3ZY4S&EAZ
MM.?-"O3P>.JSQ>6JO&I_95=JIEOU648M>G^&O#NG^$M$L?#^E7&NW-AIR2);
MS^)?%'B;QGK<BRS27#&^\2^,-7UWQ'J;AY66.34]5NY(81';1,EO##$E5*LJ
MDHRDJ<7&G2I)4J5*C'EI4XTHN4:,*<95)1@G5JR3JUZCE6K3J59SG(ITHT5*
M,74M*I.H_:5:M5J523E)1=6<W"FF_<I0<:5*-H4X0@E%31:!H,%Q!=0Z)I$-
MU:7NH:E:W,6FV<=Q;:CJRR)JM_!,D(DAO=3265=0NHV6>]661;F20.P.</W5
MO9_N[4)X9<GN6P]7$4\74PZY;6H5,51I8F=+^'/$4J=:474A&2N:4W>:4G[6
ME73G[S]M0PLL#0K7=W[6C@ISP=*I\=/"SEAX-4I.#X?X@3)#XA^#RL)<S_$N
M>)/+@FE56_X5K\1),RM#&ZV\>V-AYTYCA\PI%YGFRQH]8?\ WMQZ_P!FY@UH
MTK1G@[WE\*;O[L6U*6JBG9FLFH9;F;ULHY.M$V[SXER2*TBF[7?O2MRQC>4F
MHIM>GU)F% !0 4 % 'RU\<_BO\2O &MR0>'$\$^'/#=IX+N_$-MXI^(GA[Q7
MJ'A/Q)XEBDU.)_!]_P"-?#^MZ1H?PG73X8-*U27Q)XSAU2RUFVU&XM=,L8_[
M*U._M(H.4Z]6FUS2C6P=#"X&"C1Q.,6+G3IRQ&#Q6(J0P>(Q-*M-8:CDMZ>*
MQ=5QJ/%83#R54[(4,/[/ SE4J1A4Q6)68UJ5-UWEV$PT,-6IRE@Z2^LU(XZE
M+'_[?!O#Y=/!TX5:.+Q&.PN&GOZ7^TAX*:Z^(MCK]CXLT.;X9:CX9T36K@>
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M &3+]FS_ -)/B+0!]L4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@,MJ9=@XT%3E&K3JYWE^:U%C*DG#$\WU? QRV%;#8BC[3"^[F-#,95L5.O\
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MDL9SIRC).K1X5X?H58RE!M.I2G2=&HF^:$J;IRLX67NM9""@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MH . *EMW;>^[;WN3&,8Q48I1C%*,8Q22C%*R22T22T26B0M PH * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M>2=84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M\]S'!=VTDO1.C4HT,3B*L?J\,%"G5QD*\HT,1@Z-://1Q&*PE5PQ6&PM:/\
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M5:JI2<(3A2M37K'_  UC^RQ_T<M\ /\ P\GPZ_\ FCK$L/\ AK']EC_HY;X
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M]#]Y2E')XTE7O"M?)<)AL'1=2G!U(<N+5&6(JPC7_P!FG/V$9XE-X@XGPC\
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MY?>YK\W,MCJQ]7ECPQA^6UZ?&>(Y[VM>MP32Y.6W]WFYK];<O4^F:1F% !0
M4 % !0 4 % !0 4 % !0!#<-MMYVQ]V&5L=.B,<5YV;U/8Y3FE;EYO99=C:G
M+?EYO9X:K+EO9VO:U[.V]F:45>K2CM>I!>EY)'SE^QYJ?]L?LP?!+4?(^R^?
MX$TL>3YOG;/)::W_ -9Y<6[=Y6__ %:XW;><;C]'FE/V6(P\;WYLIR*KMRV]
MODF7UN6UW\/M.6^G-:]E>RSJ5O;YAG];E]GS\5<7>[?FY;<3YM'>T=[7V6Y]
M)UYH!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MC@\#7I\F*E&=FIXS&4*D\)AU0?-@8U,3C:E;#XO#8*CBO70 H"J H4   8
MX  '  '  Z4FW=MO7=M[W[LB,8QBHQ2C&*48QBDHQBE9)):)):)+1+1"T#"@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
. * "@ H * "@ H __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
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M5ZE1J4713:C&DJ:4#ZLK Q"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M!##RS_#2P]/#U<WK5*="%/$8?!U:^+AE.5X3\1>*?A5?SZ?X/NM+N/#7B/\
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M.NL%*C&<Z[Q%7#^THTX4:<'5K574]E2I3I5:DXTZ]&53+#5:6*P&#S.C4IK
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ME.,\Q^N^TQ5#2/)3I_7>7V/*G6CA:+E.ES\M+NT^"7QAU#3-7\":M'\,M/\
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MVC*LZ-6.)G.-#&UZ2Q#GA\0Y>PQE:MAZ.+EYK?\ [,7Q:L?"'[3/A;P=X3^
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M,*R7LJS]I[*=3V57D]8'[)_[+& 1^S5^S_CJ"/@W\.L8[$?\4Y6.VFUNFUK
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M\>_'#Q;H\.B;->;Q)\0/%^A:+;ZOH=]J?@G68FNVGY,Q>/H?V[F,(N&-RO\
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MC3T:Z,5><99KQ-*G*,H/C'C+EE!IQ?\ QE&;)V<79ZIIVZIH^EJD04 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % 'R+\'OB?HG@RTU7P#XB\+_&.P\12
M?%WXMF-XOV?OCMJ/AM[?Q/\ %OQ=JNAZBGC;2_AS>^"VT>^TW5+&_P#[:'B
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
2* "@ H * "@ H * "@ H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
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M=FHJ:B].>DYSIQK4WM5HRJ4JM.-:FY4I5*56G&;G3FH[- !0 4 % !0 4 %
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M8ZURY^&?P'\9>$+3PTWBO7_V>M=^("^#- \&ZYHVI7OB*^M_BT-'2RO==N/
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M="MEBE3P=9O"5J]/&8:G#EH5O,_'OPK^+GB6_P#VA;Z+]C744/Q8UCX1>+/
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MK2QNN<?]=CQ__A<GQ%_Z-._: _\ "C_99_\ HEJ #_A<GQ%_Z-._: _\*/\
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MC/HOAZXLKZ6\%QYF@V27C7<%WK<.K>EBL=B<74SRM5FE7X@C@WCZL(1C)8C
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MAI/"+,E']Y_:<<%"HZNCP\,!.=3#PPKI>R<(<]?%2JPJ^VC7EBG*LIRPF6O
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M:?-7Q>:X.M6JXVCB:<<V]K6Y,5A\+AX8:.$P7MFA?&CXK?\ "ROCU;ZMX7\
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J@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
